Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-27a-3p A1CF -0.61 0.09801 1.57 0.13497 MirTarget -0.66 0.00179 NA
2 hsa-miR-324-3p A4GALT -0.4 0.28459 -0.33 0.50036 MirTarget -0.22 0.02514 NA
3 hsa-miR-15a-5p A4GNT -0.74 0.01074 1.25 0.38275 MirTarget -1.28 0.00053 NA
4 hsa-miR-15b-5p A4GNT -1.17 6.0E-5 1.25 0.38275 MirTarget -1.2 0.00097 NA
5 hsa-miR-16-5p A4GNT -1.02 0.00033 1.25 0.38275 MirTarget -1.21 0.00119 NA
6 hsa-miR-342-3p AADAC -1.51 0.00036 3.68 0.00236 miRanda -0.71 0.00076 NA
7 hsa-miR-342-3p AAMP -1.51 0.00036 0.52 0.0051 PITA; miRanda; miRNATAP -0.14 1.0E-5 NA
8 hsa-miR-484 AARS -1.18 5.0E-5 0.28 0.15374 miRNAWalker2 validate -0.1 0.04135 NA
9 hsa-miR-27a-3p ABAT -0.61 0.09801 0.38 0.56796 MirTarget -0.73 0 NA
10 hsa-miR-130b-3p ABCA1 -0.37 0.37726 -0.53 0.25827 miRNATAP -0.17 0.03751 NA
11 hsa-miR-93-5p ABCA1 -0.47 0.13146 -0.53 0.25827 MirTarget; miRNATAP -0.25 0.0293 NA
12 hsa-miR-23a-3p ABCA10 -0.22 0.39943 -0.39 0.50843 MirTarget -0.78 0 NA
13 hsa-miR-320c ABCA12 -0.2 0.68946 5.05 3.0E-5 miRanda; miRNATAP -0.4 0.03911 NA
14 hsa-miR-320c ABCA13 -0.2 0.68946 2.71 0.0092 miRanda -0.34 0.03989 NA
15 hsa-miR-92a-3p ABCA3 -0.42 0.1469 -0.37 0.47178 miRNAWalker2 validate -0.39 0.0039 NA
16 hsa-miR-320a ABCA4 -0.53 0.10886 0.62 0.41421 miRanda -0.36 0.03881 NA
17 hsa-miR-320b ABCA4 -0.27 0.55127 0.62 0.41421 miRanda -0.28 0.02169 NA
18 hsa-let-7b-3p ABCA5 -0.41 0.16777 -0.26 0.57478 mirMAP -0.24 0.0379 NA
19 hsa-miR-181a-5p ABCA5 -0.1 0.77743 -0.26 0.57478 mirMAP -0.46 0 NA
20 hsa-miR-181b-5p ABCA5 0.25 0.56352 -0.26 0.57478 mirMAP -0.41 0 NA
21 hsa-let-7d-3p ABCA8 -0.55 0.04674 -0.99 0.28561 MirTarget -0.92 0.00025 NA
22 hsa-miR-320b ABCA8 -0.27 0.55127 -0.99 0.28561 miRanda -0.43 0.00409 NA
23 hsa-miR-107 ABCB5 0.04 0.89912 -1.1 0.20934 MirTarget; miRanda -0.62 0.00774 NA
24 hsa-miR-15a-5p ABCB5 -0.74 0.01074 -1.1 0.20934 MirTarget -0.52 0.02298 NA
25 hsa-miR-15b-5p ABCB5 -1.17 6.0E-5 -1.1 0.20934 MirTarget -0.62 0.00514 NA
26 hsa-miR-16-5p ABCB5 -1.02 0.00033 -1.1 0.20934 MirTarget -0.65 0.00456 NA
27 hsa-miR-150-5p ABCB9 -1.91 0.02035 0.46 0.14647 MirTarget -0.12 1.0E-5 NA
28 hsa-miR-107 ABCC3 0.04 0.89912 0.56 0.4862 miRanda; miRNATAP -0.8 0.00018 NA
29 hsa-miR-16-5p ABCC4 -1.02 0.00033 -0.33 0.49338 miRNAWalker2 validate -0.26 0.04038 NA
30 hsa-miR-486-5p ABCC6P1 -1.43 0.04021 0.9 0.32477 miRanda -0.22 0.01964 NA
31 hsa-let-7b-3p ABCC9 -0.41 0.16777 0.12 0.86565 mirMAP -0.46 0.0122 NA
32 hsa-let-7b-3p ABCD2 -0.41 0.16777 -1.98 0.01409 mirMAP -0.43 0.03495 NA
33 hsa-miR-93-5p ABCD2 -0.47 0.13146 -1.98 0.01409 MirTarget -0.42 0.03214 NA
34 hsa-miR-320a ABHD12 -0.53 0.10886 0.22 0.40184 miRanda -0.12 0.04516 NA
35 hsa-let-7i-5p ABHD14B -0.19 0.47734 0.16 0.57401 MirTarget -0.3 0.00013 NA
36 hsa-miR-181b-5p ABHD15 0.25 0.56352 0.01 0.97057 mirMAP -0.24 4.0E-5 NA
37 hsa-miR-92a-3p ABHD15 -0.42 0.1469 0.01 0.97057 miRNAWalker2 validate -0.19 0.03563 NA
38 hsa-miR-16-5p ABHD2 -1.02 0.00033 0.63 0.15716 miRNAWalker2 validate -0.48 3.0E-5 NA
39 hsa-miR-30b-3p ABHD2 -0.57 0.2349 0.63 0.15716 miRNATAP -0.19 0.00432 NA
40 hsa-miR-339-3p ABHD2 -0.6 0.11547 0.63 0.15716 PITA -0.28 0.00101 NA
41 hsa-miR-484 ABHD2 -1.18 5.0E-5 0.63 0.15716 miRNAWalker2 validate -0.37 0.00078 NA
42 hsa-miR-660-5p ABHD2 -0.2 0.55612 0.63 0.15716 mirMAP -0.26 0.00932 NA
43 hsa-miR-877-5p ABHD2 -1.17 0.04417 0.63 0.15716 mirMAP -0.14 0.01678 NA
44 hsa-miR-29c-3p ABHD5 -0.13 0.74361 -0.07 0.7607 MirTarget -0.14 0.00024 NA
45 hsa-miR-30e-5p ABHD5 -0.99 0.00042 -0.07 0.7607 MirTarget -0.16 0.00508 NA
46 hsa-miR-23a-3p ABHD6 -0.22 0.39943 -0.35 0.27768 MirTarget -0.28 0.00224 NA
47 hsa-miR-27a-3p ABHD6 -0.61 0.09801 -0.35 0.27768 miRNATAP -0.26 5.0E-5 NA
48 hsa-miR-130a-3p ABI2 -1.17 0.00035 0.12 0.58647 mirMAP -0.12 0.01693 NA
49 hsa-miR-130b-3p ABI2 -0.37 0.37726 0.12 0.58647 mirMAP -0.12 0.00098 NA
50 hsa-miR-27a-3p ABI2 -0.61 0.09801 0.12 0.58647 mirMAP -0.12 0.00527 NA
51 hsa-miR-107 ABI3BP 0.04 0.89912 -0.32 0.6724 miRanda -0.56 0.00586 NA
52 hsa-miR-92a-3p ABI3BP -0.42 0.1469 -0.32 0.6724 miRNATAP -0.52 0.00909 NA
53 hsa-miR-29a-3p ABL1 -0.39 0.22665 -0.28 0.25357 miRNAWalker2 validate; miRNATAP -0.21 0.00019 NA
54 hsa-miR-29c-3p ABL1 -0.13 0.74361 -0.28 0.25357 miRNATAP -0.15 0.0004 NA
55 hsa-miR-30d-5p ABL1 -0.01 0.97473 -0.28 0.25357 MirTarget; miRNATAP -0.15 0.01552 NA
56 hsa-let-7g-5p ABL2 -0.81 0.01579 -0.13 0.63539 miRNATAP -0.16 0.00996 NA
57 hsa-miR-29c-3p ABL2 -0.13 0.74361 -0.13 0.63539 mirMAP -0.19 0.00013 NA
58 hsa-miR-30d-5p ABL2 -0.01 0.97473 -0.13 0.63539 mirMAP; miRNATAP -0.18 0.01298 NA
59 hsa-miR-30e-5p ABL2 -0.99 0.00042 -0.13 0.63539 mirMAP -0.2 0.00741 NA
60 hsa-miR-92a-3p ABL2 -0.42 0.1469 -0.13 0.63539 miRNAWalker2 validate -0.15 0.04041 NA
61 hsa-miR-93-5p ABL2 -0.47 0.13146 -0.13 0.63539 MirTarget -0.16 0.01947 NA
62 hsa-miR-193b-5p ABLIM2 -0.15 0.80433 -0.12 0.8174 MirTarget -0.16 0.02277 NA
63 hsa-miR-15a-5p ABTB2 -0.74 0.01074 0.09 0.87066 MirTarget -0.55 9.0E-5 NA
64 hsa-miR-16-5p ABTB2 -1.02 0.00033 0.09 0.87066 MirTarget -0.33 0.02286 NA
65 hsa-miR-3614-5p ACACB -0.34 0.57178 -0.24 0.62524 mirMAP -0.13 0.04072 NA
66 hsa-miR-23a-3p ACADSB -0.22 0.39943 -0.21 0.50861 mirMAP -0.36 9.0E-5 NA
67 hsa-miR-107 ACADVL 0.04 0.89912 -0.22 0.43766 miRanda -0.19 0.01227 NA
68 hsa-miR-320a ACAT1 -0.53 0.10886 -0.37 0.29673 miRanda -0.28 0.00032 NA
69 hsa-miR-320b ACAT1 -0.27 0.55127 -0.37 0.29673 miRanda -0.14 0.01018 NA
70 hsa-miR-130a-3p ACBD3 -1.17 0.00035 0.56 0.02656 MirTarget; miRNATAP -0.13 0.01901 NA
71 hsa-miR-107 ACCS 0.04 0.89912 -0.64 0.1402 miRanda -0.29 0.01303 NA
72 hsa-miR-125a-3p ACOT13 0.43 0.36072 0.04 0.85073 MirTarget; miRanda; miRNATAP -0.11 0.00088 NA
73 hsa-miR-320a ACOT13 -0.53 0.10886 0.04 0.85073 miRanda -0.16 0.00076 NA
74 hsa-miR-23a-3p ACOX1 -0.22 0.39943 0.32 0.18102 mirMAP -0.21 0.00234 NA
75 hsa-miR-320b ACSBG1 -0.27 0.55127 0.18 0.71848 mirMAP -0.18 0.02327 NA
76 hsa-miR-30c-2-3p ACSL3 -0.62 0.13013 0.49 0.05885 MirTarget -0.12 0.01159 NA
77 hsa-miR-30e-5p ACSL3 -0.99 0.00042 0.49 0.05885 mirMAP -0.13 0.04896 NA
78 hsa-miR-342-3p ACSL3 -1.51 0.00036 0.49 0.05885 miRanda -0.19 1.0E-5 NA
79 hsa-miR-15a-5p ACSL4 -0.74 0.01074 -0.57 0.06388 MirTarget; miRNATAP -0.2 0.01323 NA
80 hsa-miR-181a-5p ACSL6 -0.1 0.77743 -0.75 0.40323 miRNATAP -0.82 1.0E-5 NA
81 hsa-miR-181b-5p ACSL6 0.25 0.56352 -0.75 0.40323 miRNATAP -0.77 0 NA
82 hsa-miR-196a-5p ACSL6 2.84 0.01406 -0.75 0.40323 miRNATAP -0.37 0 NA
83 hsa-miR-196b-5p ACSL6 1.33 0.19807 -0.75 0.40323 miRNATAP -0.38 0 NA
84 hsa-miR-24-3p ACSL6 -0.29 0.30773 -0.75 0.40323 MirTarget -1.26 0 NA
85 hsa-miR-93-5p ACSL6 -0.47 0.13146 -0.75 0.40323 mirMAP -0.87 4.0E-5 NA
86 hsa-miR-320b ACSM5 -0.27 0.55127 -2.35 0.00202 miRanda -0.26 0.03838 NA
87 hsa-miR-30d-5p ACTBL2 -0.01 0.97473 1.45 0.14365 MirTarget -0.93 0.0002 NA
88 hsa-miR-30e-5p ACTBL2 -0.99 0.00042 1.45 0.14365 MirTarget -0.61 0.02051 NA
89 hsa-miR-25-3p ACTC1 -0.61 0.02458 0.73 0.51224 MirTarget -0.62 0.04888 NA
90 hsa-miR-107 ACTG2 0.04 0.89912 0.67 0.55281 miRanda -1.08 0.00029 NA
91 hsa-miR-16-5p ACTN1 -1.02 0.00033 -0.03 0.91562 miRNAWalker2 validate -0.35 1.0E-5 NA
92 hsa-miR-30d-5p ACTN1 -0.01 0.97473 -0.03 0.91562 miRNATAP -0.38 0 NA
93 hsa-miR-16-5p ACTN4 -1.02 0.00033 0.21 0.5222 miRNAWalker2 validate -0.22 0.00942 NA
94 hsa-miR-29c-3p ACTN4 -0.13 0.74361 0.21 0.5222 mirMAP -0.3 0 NA
95 hsa-miR-324-3p ACTN4 -0.4 0.28459 0.21 0.5222 miRNAWalker2 validate; PITA; miRNATAP -0.23 0.00029 NA
96 hsa-miR-92a-3p ACTR1A -0.42 0.1469 -0.03 0.85153 miRNAWalker2 validate -0.11 0.00569 NA
97 hsa-let-7g-5p ACTR2 -0.81 0.01579 -0.38 0.12012 miRNATAP -0.17 0.00146 NA
98 hsa-miR-15a-5p ACTR2 -0.74 0.01074 -0.38 0.12012 MirTarget; miRNATAP -0.2 0.00123 NA
99 hsa-miR-320a ACTR3C -0.53 0.10886 0.02 0.95098 mirMAP -0.38 3.0E-5 NA
100 hsa-miR-130b-3p ACVR1 -0.37 0.37726 0.3 0.22609 miRNAWalker2 validate; MirTarget; miRNATAP -0.15 0.0005 NA
101 hsa-miR-197-3p ACVR1 -0.93 0.00091 0.3 0.22609 miRNAWalker2 validate -0.18 0.0068 NA
102 hsa-miR-30d-5p ACVR1 -0.01 0.97473 0.3 0.22609 MirTarget; miRNATAP -0.24 0.0001 NA
103 hsa-miR-30e-5p ACVR1 -0.99 0.00042 0.3 0.22609 MirTarget -0.32 0 NA
104 hsa-let-7g-5p ACVR1B -0.81 0.01579 0.33 0.28594 miRNATAP -0.16 0.0193 NA
105 hsa-miR-15a-5p ACVR1B -0.74 0.01074 0.33 0.28594 miRNAWalker2 validate -0.19 0.02059 NA
106 hsa-miR-320c ACVR1B -0.2 0.68946 0.33 0.28594 mirMAP -0.12 0.01262 NA
107 hsa-miR-342-3p ACVR1B -1.51 0.00036 0.33 0.28594 MirTarget; PITA; mirMAP -0.12 0.02644 NA
108 hsa-let-7g-5p ACVR2A -0.81 0.01579 0.04 0.85285 miRNATAP -0.1 0.03637 NA
109 hsa-miR-130b-3p ACVR2A -0.37 0.37726 0.04 0.85285 miRNATAP -0.13 0.0008 NA
110 hsa-miR-15a-5p ACVR2A -0.74 0.01074 0.04 0.85285 MirTarget; miRNATAP -0.13 0.02472 NA
111 hsa-miR-15b-5p ACVR2A -1.17 6.0E-5 0.04 0.85285 MirTarget; miRNATAP -0.11 0.03894 NA
112 hsa-miR-16-5p ACVR2A -1.02 0.00033 0.04 0.85285 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.19 0.001 NA
113 hsa-miR-27a-3p ACVR2A -0.61 0.09801 0.04 0.85285 miRNATAP -0.11 0.00971 NA
114 hsa-miR-140-3p ACVR2B -0.4 0.20944 -0.22 0.43151 miRNAWalker2 validate; PITA; miRNATAP -0.18 0.00488 NA
115 hsa-miR-320a ACVR2B -0.53 0.10886 -0.22 0.43151 miRNATAP -0.15 0.01851 NA
116 hsa-miR-940 ACVRL1 -0.82 0.11739 -0.37 0.23741 mirMAP -0.17 0.00013 NA
117 hsa-miR-181b-5p ADAM11 0.25 0.56352 -0.08 0.89144 MirTarget; miRNATAP -0.3 0.00193 NA
118 hsa-miR-221-3p ADAM11 0.25 0.60279 -0.08 0.89144 miRNATAP -0.21 0.01791 NA
119 hsa-miR-130b-3p ADAM12 -0.37 0.37726 -1.12 0.25198 miRNATAP -0.35 0.04502 NA
120 hsa-miR-29a-3p ADAM12 -0.39 0.22665 -1.12 0.25198 miRNATAP -0.55 0.01546 25886595 ADAM12 L is a direct target of the miR 29 and miR 200 families in breast cancer
121 hsa-miR-29c-3p ADAM12 -0.13 0.74361 -1.12 0.25198 miRNATAP -1.14 0 NA
122 hsa-miR-29c-3p ADAM19 -0.13 0.74361 -0.94 0.15618 MirTarget; miRNATAP -0.59 0 NA
123 hsa-miR-30b-3p ADAM19 -0.57 0.2349 -0.94 0.15618 MirTarget -0.26 0.01139 NA
124 hsa-miR-30d-5p ADAM19 -0.01 0.97473 -0.94 0.15618 MirTarget; miRNATAP -0.9 0 NA
125 hsa-miR-130b-3p ADAM22 -0.37 0.37726 -0.88 0.25527 mirMAP -0.53 0.0001 NA
126 hsa-miR-29a-3p ADAM22 -0.39 0.22665 -0.88 0.25527 miRNATAP -0.46 0.01138 NA
127 hsa-miR-29c-3p ADAM22 -0.13 0.74361 -0.88 0.25527 miRNATAP -0.38 0.00739 NA
128 hsa-miR-30d-5p ADAM22 -0.01 0.97473 -0.88 0.25527 MirTarget; miRNATAP -0.42 0.03522 NA
129 hsa-miR-92a-3p ADAM22 -0.42 0.1469 -0.88 0.25527 mirMAP -0.71 0.00044 NA
130 hsa-miR-93-5p ADAM22 -0.47 0.13146 -0.88 0.25527 MirTarget; mirMAP -0.49 0.00862 NA
131 hsa-let-7b-3p ADAM23 -0.41 0.16777 0.43 0.58572 mirMAP -0.52 0.00888 NA
132 hsa-miR-92a-3p ADAM23 -0.42 0.1469 0.43 0.58572 miRNATAP -1.13 0 NA
133 hsa-miR-296-5p ADAM33 -1.02 0.0303 -0.34 0.65055 miRNATAP -0.27 0.01977 NA
134 hsa-miR-342-3p ADAM9 -1.51 0.00036 0.41 0.38674 miRanda -0.2 0.01279 NA
135 hsa-miR-107 ADAMTS1 0.04 0.89912 -0.26 0.68323 miRanda -0.35 0.03788 NA
136 hsa-miR-92a-3p ADAMTS1 -0.42 0.1469 -0.26 0.68323 miRNAWalker2 validate -0.71 1.0E-5 NA
137 hsa-miR-22-3p ADAMTS13 0.02 0.94029 0.09 0.85937 mirMAP -1.09 0 NA
138 hsa-miR-3614-5p ADAMTS13 -0.34 0.57178 0.09 0.85937 mirMAP -0.16 0.00788 NA
139 hsa-miR-107 ADAMTS14 0.04 0.89912 -0.08 0.91758 miRanda -0.75 0.00014 NA
140 hsa-miR-339-3p ADAMTS14 -0.6 0.11547 -0.08 0.91758 MirTarget -0.81 0 NA
141 hsa-miR-130b-3p ADAMTS18 -0.37 0.37726 1.13 0.16158 miRNATAP -0.44 0.00193 NA
142 hsa-miR-29a-3p ADAMTS2 -0.39 0.22665 0 0.99864 MirTarget; miRNATAP -0.57 4.0E-5 NA
143 hsa-miR-29c-3p ADAMTS2 -0.13 0.74361 0 0.99864 MirTarget; miRNATAP -0.58 0 NA
144 hsa-miR-107 ADAMTS3 0.04 0.89912 -0.85 0.21039 miRanda -0.41 0.02486 NA
145 hsa-miR-15a-5p ADAMTS3 -0.74 0.01074 -0.85 0.21039 miRNATAP -0.47 0.00735 NA
146 hsa-miR-16-5p ADAMTS3 -1.02 0.00033 -0.85 0.21039 miRNATAP -0.41 0.02157 NA
147 hsa-miR-30d-5p ADAMTS3 -0.01 0.97473 -0.85 0.21039 miRNATAP -0.85 0 NA
148 hsa-miR-320b ADAMTS3 -0.27 0.55127 -0.85 0.21039 mirMAP -0.24 0.02841 NA
149 hsa-let-7g-5p ADAMTS5 -0.81 0.01579 -0.73 0.15695 miRNATAP -0.53 0 NA
150 hsa-miR-15a-5p ADAMTS5 -0.74 0.01074 -0.73 0.15695 miRNATAP -0.28 0.0362 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 588 1402 1.853e-51 8.623e-48
2 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 653 1672 1.604e-44 3.733e-41
3 REGULATION OF CELL DIFFERENTIATION 580 1492 1.24e-38 1.254e-35
4 CELL DEVELOPMENT 560 1426 1.004e-38 1.254e-35
5 CARDIOVASCULAR SYSTEM DEVELOPMENT 355 788 1.616e-38 1.254e-35
6 CIRCULATORY SYSTEM DEVELOPMENT 355 788 1.616e-38 1.254e-35
7 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 431 1021 3.216e-38 2.138e-35
8 NEURON DIFFERENTIATION 380 874 5.15e-37 2.995e-34
9 REGULATION OF CELL DEVELOPMENT 362 836 8.068e-35 4.171e-32
10 TISSUE DEVELOPMENT 575 1518 1.478e-34 6.876e-32
11 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 450 1142 2.189e-31 9.261e-29
12 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 323 750 1.393e-30 5.059e-28
13 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 243 513 1.413e-30 5.059e-28
14 ORGAN MORPHOGENESIS 352 841 2.328e-30 7.738e-28
15 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 487 1275 3.699e-30 1.147e-27
16 INTRACELLULAR SIGNAL TRANSDUCTION 575 1572 8.018e-30 2.332e-27
17 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 385 957 5.787e-29 1.584e-26
18 VASCULATURE DEVELOPMENT 224 469 6.794e-29 1.756e-26
19 REGULATION OF NEURON DIFFERENTIATION 253 554 1.009e-28 2.472e-26
20 LOCOMOTION 433 1114 1.105e-28 2.571e-26
21 TUBE DEVELOPMENT 252 552 1.387e-28 2.933e-26
22 REGULATION OF CELL MORPHOGENESIS 252 552 1.387e-28 2.933e-26
23 NEURON DEVELOPMENT 297 687 1.649e-28 3.336e-26
24 NEURON PROJECTION DEVELOPMENT 249 545 2.559e-28 4.962e-26
25 POSITIVE REGULATION OF MOLECULAR FUNCTION 632 1791 6.824e-28 1.27e-25
26 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 592 1656 1.021e-27 1.827e-25
27 TISSUE MORPHOGENESIS 243 533 1.718e-27 2.961e-25
28 REGULATION OF TRANSPORT 634 1804 1.93e-27 3.207e-25
29 POSITIVE REGULATION OF GENE EXPRESSION 607 1733 8.186e-26 1.313e-23
30 HEART DEVELOPMENT 216 466 1.021e-25 1.584e-23
31 CELLULAR COMPONENT MORPHOGENESIS 356 900 3.117e-25 4.678e-23
32 NEURON PROJECTION MORPHOGENESIS 192 402 6.354e-25 9.239e-23
33 REGULATION OF CELLULAR COMPONENT MOVEMENT 314 771 9.294e-25 1.31e-22
34 REGULATION OF NEURON PROJECTION DEVELOPMENT 193 408 2.059e-24 2.756e-22
35 PROTEIN LOCALIZATION 622 1805 2.073e-24 2.756e-22
36 POSITIVE REGULATION OF CELL COMMUNICATION 543 1532 2.166e-24 2.8e-22
37 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 167 337 5.223e-24 6.396e-22
38 REGULATION OF CELL PROJECTION ORGANIZATION 243 558 5.104e-24 6.396e-22
39 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 178 368 5.638e-24 6.726e-22
40 REGULATION OF PHOSPHORUS METABOLIC PROCESS 566 1618 6.87e-24 7.991e-22
41 BLOOD VESSEL MORPHOGENESIS 176 364 1.07e-23 1.214e-21
42 POSITIVE REGULATION OF CELL DIFFERENTIATION 326 823 2.796e-23 3.098e-21
43 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 617 1805 3.153e-23 3.412e-21
44 NEGATIVE REGULATION OF CELL COMMUNICATION 438 1192 3.938e-23 4.165e-21
45 CELL PROJECTION ORGANIZATION 349 902 8.481e-23 8.769e-21
46 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 608 1784 1.574e-22 1.592e-20
47 BIOLOGICAL ADHESION 387 1032 2.69e-22 2.663e-20
48 EMBRYONIC MORPHOGENESIS 232 539 3.587e-22 3.478e-20
49 POSITIVE REGULATION OF CATALYTIC ACTIVITY 530 1518 3.753e-22 3.564e-20
50 MUSCLE STRUCTURE DEVELOPMENT 196 432 4.422e-22 4.116e-20
51 CENTRAL NERVOUS SYSTEM DEVELOPMENT 337 872 6.095e-22 5.561e-20
52 MORPHOGENESIS OF AN EPITHELIUM 184 400 1.274e-21 1.14e-19
53 TUBE MORPHOGENESIS 157 323 1.446e-21 1.269e-19
54 EMBRYO DEVELOPMENT 342 894 2.104e-21 1.813e-19
55 REGULATION OF PROTEIN MODIFICATION PROCESS 581 1710 3.56e-21 3.012e-19
56 POSITIVE REGULATION OF CELL DEVELOPMENT 207 472 4.584e-21 3.809e-19
57 REGULATION OF CELL PROLIFERATION 519 1496 5.011e-21 4.09e-19
58 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 489 1395 7.639e-21 6.128e-19
59 EPITHELIUM DEVELOPMENT 355 945 1.186e-20 9.351e-19
60 RESPONSE TO ENDOGENOUS STIMULUS 504 1450 1.293e-20 1.003e-18
61 CELL MOTILITY 321 835 1.605e-20 1.204e-18
62 LOCALIZATION OF CELL 321 835 1.605e-20 1.204e-18
63 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 372 1004 2.01e-20 1.484e-18
64 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 477 1360 2.154e-20 1.566e-18
65 UROGENITAL SYSTEM DEVELOPMENT 146 299 2.201e-20 1.576e-18
66 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 373 1008 2.289e-20 1.614e-18
67 SKELETAL SYSTEM DEVELOPMENT 197 455 2.395e-19 1.661e-17
68 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 191 437 2.462e-19 1.661e-17
69 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 272 689 2.451e-19 1.661e-17
70 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 611 1848 3.35e-19 2.227e-17
71 REGULATION OF KINASE ACTIVITY 297 776 9.788e-19 6.414e-17
72 REGULATION OF CELL DEATH 502 1472 1.153e-18 7.449e-17
73 CELL PART MORPHOGENESIS 252 633 1.542e-18 9.693e-17
74 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 304 801 1.53e-18 9.693e-17
75 HEAD DEVELOPMENT 275 709 2.554e-18 1.585e-16
76 REGULATION OF CELLULAR LOCALIZATION 443 1277 5.41e-18 3.312e-16
77 PROTEIN PHOSPHORYLATION 345 944 6.19e-18 3.74e-16
78 POSITIVE REGULATION OF RESPONSE TO STIMULUS 627 1929 7.569e-18 4.515e-16
79 ANGIOGENESIS 138 293 1.264e-17 7.447e-16
80 POSITIVE REGULATION OF NEURON DIFFERENTIATION 142 306 2.146e-17 1.248e-15
81 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 637 1977 3.378e-17 1.941e-15
82 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 501 1492 3.547e-17 2.013e-15
83 NEURON PROJECTION GUIDANCE 105 205 6.961e-17 3.902e-15
84 BEHAVIOR 210 516 7.248e-17 4.015e-15
85 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 114 232 1.782e-16 9.755e-15
86 SINGLE ORGANISM BEHAVIOR 166 384 1.981e-16 1.072e-14
87 ESTABLISHMENT OF PROTEIN LOCALIZATION 477 1423 3.17e-16 1.687e-14
88 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 350 983 3.191e-16 1.687e-14
89 VESICLE MEDIATED TRANSPORT 424 1239 3.988e-16 2.085e-14
90 REGULATION OF DEVELOPMENTAL GROWTH 133 289 5.102e-16 2.638e-14
91 ESTABLISHMENT OF LOCALIZATION IN CELL 546 1676 8.998e-16 4.601e-14
92 NEGATIVE REGULATION OF CELL PROLIFERATION 246 643 1.107e-15 5.597e-14
93 EMBRYONIC ORGAN DEVELOPMENT 171 406 1.356e-15 6.784e-14
94 CELLULAR MACROMOLECULE LOCALIZATION 420 1234 1.508e-15 7.465e-14
95 RESPONSE TO GROWTH FACTOR 193 475 1.609e-15 7.882e-14
96 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 112 232 1.631e-15 7.907e-14
97 MUSCLE TISSUE DEVELOPMENT 127 275 1.669e-15 8.007e-14
98 POSITIVE REGULATION OF HYDROLASE ACTIVITY 324 905 1.845e-15 8.759e-14
99 POSITIVE REGULATION OF KINASE ACTIVITY 195 482 1.921e-15 9.03e-14
100 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 362 1036 2.328e-15 1.072e-13
101 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 362 1036 2.328e-15 1.072e-13
102 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 136 303 2.899e-15 1.322e-13
103 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 217 554 3.125e-15 1.412e-13
104 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 395 1152 3.188e-15 1.424e-13
105 NEGATIVE REGULATION OF CELL DIFFERENTIATION 234 609 3.213e-15 1.424e-13
106 REGULATION OF TRANSFERASE ACTIVITY 335 946 3.43e-15 1.506e-13
107 MEMBRANE ORGANIZATION 321 899 3.786e-15 1.646e-13
108 REGULATION OF GTPASE ACTIVITY 253 673 4.781e-15 2.06e-13
109 SENSORY ORGAN DEVELOPMENT 197 493 5.994e-15 2.559e-13
110 DIGESTIVE SYSTEM DEVELOPMENT 80 148 6.88e-15 2.91e-13
111 REGULATION OF PROTEIN LOCALIZATION 334 950 1.17e-14 4.904e-13
112 PHOSPHORYLATION 414 1228 1.32e-14 5.485e-13
113 REGULATION OF ION TRANSPORT 226 592 2.172e-14 8.944e-13
114 MESENCHYME DEVELOPMENT 94 190 4.576e-14 1.868e-12
115 POSITIVE REGULATION OF LOCOMOTION 171 420 5.385e-14 2.179e-12
116 EXTRACELLULAR STRUCTURE ORGANIZATION 133 304 6.504e-14 2.609e-12
117 POSITIVE REGULATION OF CELL PROLIFERATION 291 814 6.612e-14 2.629e-12
118 REGULATION OF MAPK CASCADE 245 660 6.698e-14 2.641e-12
119 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 383 1135 1.215e-13 4.751e-12
120 REGULATION OF MEMBRANE POTENTIAL 145 343 1.388e-13 5.383e-12
121 RESPONSE TO OXYGEN CONTAINING COMPOUND 452 1381 1.628e-13 6.261e-12
122 NEGATIVE REGULATION OF CELL DEATH 306 872 2.111e-13 7.984e-12
123 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 185 470 2.098e-13 7.984e-12
124 MUSCLE CELL DIFFERENTIATION 109 237 2.313e-13 8.679e-12
125 REGULATION OF ANATOMICAL STRUCTURE SIZE 185 472 3.306e-13 1.231e-11
126 REGULATION OF AXONOGENESIS 84 168 4.799e-13 1.772e-11
127 COGNITION 113 251 4.974e-13 1.823e-11
128 REGULATION OF HYDROLASE ACTIVITY 434 1327 5.928e-13 2.155e-11
129 MESENCHYMAL CELL DIFFERENTIATION 71 134 8.235e-13 2.97e-11
130 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 282 799 9.104e-13 3.258e-11
131 MODULATION OF SYNAPTIC TRANSMISSION 129 301 9.476e-13 3.366e-11
132 MORPHOGENESIS OF A BRANCHING STRUCTURE 83 167 1e-12 3.526e-11
133 EYE DEVELOPMENT 137 326 1.108e-12 3.876e-11
134 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 304 876 1.186e-12 4.119e-11
135 STEM CELL DIFFERENTIATION 91 190 1.26e-12 4.343e-11
136 ACTIN FILAMENT BASED PROCESS 176 450 1.55e-12 5.303e-11
137 NEGATIVE REGULATION OF GENE EXPRESSION 478 1493 1.615e-12 5.485e-11
138 REGULATION OF CELLULAR COMPONENT SIZE 140 337 1.773e-12 5.978e-11
139 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 104 229 2.151e-12 7.2e-11
140 GROWTH 163 410 2.19e-12 7.278e-11
141 REGULATION OF CELLULAR COMPONENT BIOGENESIS 271 767 2.245e-12 7.409e-11
142 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 263 740 2.318e-12 7.597e-11
143 FOREBRAIN DEVELOPMENT 146 357 2.513e-12 8.178e-11
144 GLAND DEVELOPMENT 158 395 2.682e-12 8.665e-11
145 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 190 498 2.814e-12 9.03e-11
146 SYNAPSE ORGANIZATION 74 145 3.174e-12 1.012e-10
147 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 80 162 3.912e-12 1.238e-10
148 REGULATION OF EPITHELIAL CELL PROLIFERATION 122 285 4.292e-12 1.349e-10
149 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 225 616 4.633e-12 1.447e-10
150 CELL DEATH 337 1001 5.544e-12 1.708e-10
151 CONNECTIVE TISSUE DEVELOPMENT 91 194 5.523e-12 1.708e-10
152 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 170 437 6.275e-12 1.921e-10
153 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 81 166 6.36e-12 1.934e-10
154 CELL CELL ADHESION 222 608 6.705e-12 2.026e-10
155 REGULATION OF GROWTH 229 633 8.891e-12 2.669e-10
156 ARTERY DEVELOPMENT 46 75 1.02e-11 3.043e-10
157 TELENCEPHALON DEVELOPMENT 102 228 1.062e-11 3.147e-10
158 POSITIVE REGULATION OF CELL DEATH 220 605 1.311e-11 3.862e-10
159 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 122 289 1.323e-11 3.871e-10
160 MUSCLE ORGAN DEVELOPMENT 118 277 1.408e-11 4.093e-10
161 RESPONSE TO HORMONE 304 893 1.539e-11 4.448e-10
162 DEVELOPMENTAL GROWTH 136 333 1.577e-11 4.528e-10
163 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 479 1517 1.639e-11 4.679e-10
164 REGULATION OF SYSTEM PROCESS 190 507 1.758e-11 4.988e-10
165 HEART MORPHOGENESIS 96 212 1.834e-11 5.172e-10
166 REGULATION OF VESICLE MEDIATED TRANSPORT 176 462 2.075e-11 5.816e-10
167 NEGATIVE REGULATION OF CELL DEVELOPMENT 126 303 2.09e-11 5.822e-10
168 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 200 541 2.129e-11 5.863e-10
169 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 200 541 2.129e-11 5.863e-10
170 EMBRYONIC ORGAN MORPHOGENESIS 118 279 2.466e-11 6.748e-10
171 SINGLE ORGANISM CELLULAR LOCALIZATION 304 898 3.165e-11 8.613e-10
172 NEGATIVE REGULATION OF PHOSPHORYLATION 163 422 3.284e-11 8.885e-10
173 REGULATION OF ACTIN FILAMENT BASED PROCESS 128 312 4.327e-11 1.164e-09
174 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 117 278 4.358e-11 1.165e-09
175 REGULATION OF CELL ADHESION 225 629 4.652e-11 1.237e-09
176 APPENDAGE DEVELOPMENT 80 169 5.894e-11 1.549e-09
177 LIMB DEVELOPMENT 80 169 5.894e-11 1.549e-09
178 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 93 207 6.416e-11 1.677e-09
179 ION TRANSPORT 405 1262 6.787e-11 1.764e-09
180 CELL SUBSTRATE ADHESION 78 164 7.645e-11 1.976e-09
181 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 66 131 9.604e-11 2.469e-09
182 CELL JUNCTION ORGANIZATION 85 185 1.035e-10 2.647e-09
183 REGULATION OF MAP KINASE ACTIVITY 129 319 1.144e-10 2.908e-09
184 REGULATION OF SYNAPTIC PLASTICITY 69 140 1.289e-10 3.26e-09
185 ACTIVATION OF PROTEIN KINASE ACTIVITY 116 279 1.31e-10 3.294e-09
186 SINGLE ORGANISM CELL ADHESION 172 459 1.608e-10 4.021e-09
187 REGULATION OF CELL SIZE 80 172 1.738e-10 4.326e-09
188 REGULATION OF SECRETION 243 699 1.931e-10 4.779e-09
189 POSITIVE REGULATION OF MAPK CASCADE 175 470 2.003e-10 4.931e-09
190 ENDOTHELIUM DEVELOPMENT 50 90 2.086e-10 5.108e-09
191 TAXIS 173 464 2.249e-10 5.478e-09
192 WNT SIGNALING PATHWAY 138 351 2.602e-10 6.306e-09
193 REGULATION OF VASCULATURE DEVELOPMENT 100 233 3.008e-10 7.252e-09
194 CELL FATE COMMITMENT 98 227 3.056e-10 7.33e-09
195 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 55 104 3.308e-10 7.893e-09
196 CARDIAC MUSCLE TISSUE DEVELOPMENT 68 140 3.931e-10 9.331e-09
197 REGULATION OF METAL ION TRANSPORT 129 325 4.826e-10 1.14e-08
198 POSITIVE REGULATION OF TRANSPORT 309 936 5.137e-10 1.207e-08
199 STRIATED MUSCLE CELL DIFFERENTIATION 79 173 6.687e-10 1.548e-08
200 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 137 352 6.685e-10 1.548e-08
201 REGULATION OF CELL SUBSTRATE ADHESION 79 173 6.687e-10 1.548e-08
202 REGULATION OF HOMEOSTATIC PROCESS 166 447 7.329e-10 1.688e-08
203 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 236 684 7.813e-10 1.791e-08
204 PATTERN SPECIFICATION PROCESS 157 418 8.291e-10 1.891e-08
205 RESPONSE TO NITROGEN COMPOUND 286 859 8.821e-10 2.002e-08
206 LEARNING 64 131 9.432e-10 2.131e-08
207 EPITHELIAL CELL DIFFERENTIATION 180 495 9.642e-10 2.167e-08
208 HOMEOSTATIC PROCESS 419 1337 1.025e-09 2.292e-08
209 AMEBOIDAL TYPE CELL MIGRATION 72 154 1.049e-09 2.335e-08
210 REGULATION OF TRANSMEMBRANE TRANSPORT 159 426 1.099e-09 2.434e-08
211 REGULATION OF ORGAN MORPHOGENESIS 101 242 1.57e-09 3.463e-08
212 CHEMICAL HOMEOSTASIS 289 874 1.585e-09 3.479e-08
213 REGULATION OF CELLULAR PROTEIN LOCALIZATION 196 552 1.662e-09 3.631e-08
214 CELLULAR RESPONSE TO NITROGEN COMPOUND 182 505 1.733e-09 3.765e-08
215 RESPONSE TO ABIOTIC STIMULUS 331 1024 1.74e-09 3.765e-08
216 PROTEIN LOCALIZATION TO MEMBRANE 143 376 1.782e-09 3.836e-08
217 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 68 144 1.789e-09 3.836e-08
218 RESPIRATORY SYSTEM DEVELOPMENT 86 197 1.895e-09 4.045e-08
219 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 72 156 2.12e-09 4.504e-08
220 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 107 262 2.247e-09 4.752e-08
221 KIDNEY EPITHELIUM DEVELOPMENT 61 125 2.447e-09 5.151e-08
222 POSITIVE REGULATION OF MAP KINASE ACTIVITY 89 207 2.512e-09 5.265e-08
223 SKELETAL SYSTEM MORPHOGENESIS 87 201 2.546e-09 5.313e-08
224 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 151 404 2.567e-09 5.333e-08
225 REGULATION OF WNT SIGNALING PATHWAY 122 310 2.603e-09 5.383e-08
226 ENDOTHELIAL CELL DIFFERENTIATION 41 72 3.232e-09 6.654e-08
227 CELL CELL SIGNALING 257 767 3.32e-09 6.806e-08
228 CARDIAC SEPTUM DEVELOPMENT 46 85 3.429e-09 6.99e-08
229 REGULATION OF EXTENT OF CELL GROWTH 52 101 3.44e-09 6.99e-08
230 REGULATION OF CELLULAR RESPONSE TO STRESS 235 691 3.681e-09 7.447e-08
231 DIGESTIVE TRACT MORPHOGENESIS 31 48 3.966e-09 7.988e-08
232 NEURAL CREST CELL DIFFERENTIATION 42 75 4.156e-09 8.335e-08
233 CARDIAC CHAMBER DEVELOPMENT 67 144 5.032e-09 1.005e-07
234 CELLULAR RESPONSE TO HORMONE STIMULUS 194 552 5.08e-09 1.01e-07
235 CARTILAGE DEVELOPMENT 68 147 5.226e-09 1.035e-07
236 REGULATION OF SYNAPSE ORGANIZATION 56 113 5.359e-09 1.052e-07
237 REGULATION OF STEM CELL DIFFERENTIATION 56 113 5.359e-09 1.052e-07
238 ACTION POTENTIAL 49 94 5.658e-09 1.106e-07
239 EPITHELIAL CELL DEVELOPMENT 81 186 6.341e-09 1.235e-07
240 RESPONSE TO ORGANIC CYCLIC COMPOUND 298 917 6.425e-09 1.246e-07
241 GLAND MORPHOGENESIS 50 97 6.499e-09 1.255e-07
242 SECRETION BY CELL 174 486 6.86e-09 1.319e-07
243 LOCOMOTORY BEHAVIOR 79 181 8.584e-09 1.637e-07
244 REGULATION OF OSSIFICATION 78 178 8.58e-09 1.637e-07
245 REPRODUCTIVE SYSTEM DEVELOPMENT 150 408 1.04e-08 1.967e-07
246 SYNAPSE ASSEMBLY 39 69 1.038e-08 1.967e-07
247 REGULATION OF HORMONE SECRETION 105 262 1.058e-08 1.992e-07
248 CELL JUNCTION ASSEMBLY 61 129 1.127e-08 2.114e-07
249 REGULATION OF CATABOLIC PROCESS 244 731 1.22e-08 2.28e-07
250 CELL PROLIFERATION 227 672 1.297e-08 2.415e-07
251 INTRACELLULAR PROTEIN TRANSPORT 258 781 1.345e-08 2.493e-07
252 REGULATION OF TRANSPORTER ACTIVITY 84 198 1.473e-08 2.72e-07
253 OSSIFICATION 101 251 1.564e-08 2.865e-07
254 REGULATION OF CHEMOTAXIS 78 180 1.564e-08 2.865e-07
255 TRANSMEMBRANE TRANSPORT 346 1098 1.69e-08 3.083e-07
256 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 87 208 1.836e-08 3.337e-07
257 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 210 616 2.018e-08 3.654e-07
258 CELLULAR RESPONSE TO ACID CHEMICAL 76 175 2.121e-08 3.81e-07
259 GLIOGENESIS 76 175 2.121e-08 3.81e-07
260 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 62 134 2.409e-08 4.311e-07
261 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 342 1087 2.462e-08 4.39e-07
262 REGULATION OF INTRACELLULAR TRANSPORT 211 621 2.518e-08 4.472e-07
263 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 81 191 2.699e-08 4.775e-07
264 NEURAL TUBE DEVELOPMENT 67 149 2.741e-08 4.831e-07
265 MULTICELLULAR ORGANISMAL SIGNALING 58 123 2.903e-08 5.097e-07
266 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 240 724 3.124e-08 5.465e-07
267 SECRETION 201 588 3.208e-08 5.59e-07
268 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 68 153 3.826e-08 6.643e-07
269 NEURON MIGRATION 53 110 4.595e-08 7.948e-07
270 REGULATION OF NEUROTRANSMITTER LEVELS 80 190 4.78e-08 8.206e-07
271 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 80 190 4.78e-08 8.206e-07
272 CYTOSOLIC TRANSPORT 88 215 5.106e-08 8.734e-07
273 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 57 122 5.71e-08 9.707e-07
274 PLASMA MEMBRANE ORGANIZATION 84 203 5.716e-08 9.707e-07
275 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 164 465 5.909e-08 9.962e-07
276 ENDOMEMBRANE SYSTEM ORGANIZATION 164 465 5.909e-08 9.962e-07
277 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 82 197 6.006e-08 1.009e-06
278 REGULATION OF CELL GROWTH 142 391 6.094e-08 1.02e-06
279 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 55 117 7.479e-08 1.247e-06
280 REGULATION OF DENDRITE DEVELOPMENT 56 120 7.82e-08 1.299e-06
281 RESPONSE TO WOUNDING 192 563 7.897e-08 1.308e-06
282 REGULATION OF MUSCLE SYSTEM PROCESS 81 195 8.026e-08 1.324e-06
283 EXOCYTOSIS 117 310 8.416e-08 1.384e-06
284 CARDIAC VENTRICLE DEVELOPMENT 51 106 8.675e-08 1.416e-06
285 TUBE FORMATION 59 129 8.673e-08 1.416e-06
286 NEPHRON DEVELOPMENT 54 115 1.025e-07 1.668e-06
287 REGULATION OF CARTILAGE DEVELOPMENT 35 63 1.056e-07 1.711e-06
288 REGULATION OF LIPID METABOLIC PROCESS 108 282 1.102e-07 1.775e-06
289 REGULATION OF BLOOD CIRCULATION 112 295 1.102e-07 1.775e-06
290 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 77 184 1.149e-07 1.844e-06
291 GLIAL CELL DIFFERENTIATION 61 136 1.26e-07 2.015e-06
292 REGULATION OF CHONDROCYTE DIFFERENTIATION 28 46 1.449e-07 2.309e-06
293 PALATE DEVELOPMENT 43 85 1.467e-07 2.33e-06
294 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 48 99 1.53e-07 2.414e-06
295 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 48 99 1.53e-07 2.414e-06
296 RESPONSE TO MECHANICAL STIMULUS 85 210 1.536e-07 2.415e-06
297 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 49 102 1.638e-07 2.567e-06
298 NEGATIVE REGULATION OF TRANSPORT 160 458 1.717e-07 2.681e-06
299 SENSORY ORGAN MORPHOGENESIS 94 239 1.73e-07 2.692e-06
300 ENSHEATHMENT OF NEURONS 45 91 1.793e-07 2.772e-06
301 AXON ENSHEATHMENT 45 91 1.793e-07 2.772e-06
302 PROTEIN AUTOPHOSPHORYLATION 79 192 1.856e-07 2.86e-06
303 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 24 37 2.042e-07 3.135e-06
304 MUSCLE SYSTEM PROCESS 107 282 2.171e-07 3.322e-06
305 RESPONSE TO ALCOHOL 131 362 2.458e-07 3.749e-06
306 REGULATION OF CYTOPLASMIC TRANSPORT 166 481 2.502e-07 3.805e-06
307 RESPONSE TO ACID CHEMICAL 118 319 2.583e-07 3.914e-06
308 REGULATION OF PEPTIDE SECRETION 84 209 2.598e-07 3.925e-06
309 REGULATION OF OSTEOBLAST DIFFERENTIATION 52 112 2.75e-07 4.141e-06
310 METANEPHROS DEVELOPMENT 41 81 2.783e-07 4.177e-06
311 REGULATION OF APOPTOTIC SIGNALING PATHWAY 131 363 2.934e-07 4.389e-06
312 REGULATION OF ORGAN GROWTH 38 73 2.977e-07 4.44e-06
313 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 42 84 3.094e-07 4.599e-06
314 PEPTIDYL SERINE MODIFICATION 64 148 3.22e-07 4.772e-06
315 NEURON RECOGNITION 22 33 3.234e-07 4.778e-06
316 RESPONSE TO STEROID HORMONE 170 497 3.48e-07 5.124e-06
317 ORGAN GROWTH 36 68 3.52e-07 5.167e-06
318 REGULATION OF CELL MATRIX ADHESION 44 90 3.697e-07 5.41e-06
319 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 92 236 3.724e-07 5.432e-06
320 SIGNAL RELEASE 72 173 3.767e-07 5.46e-06
321 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 51 110 3.766e-07 5.46e-06
322 CELL MATRIX ADHESION 54 119 4.111e-07 5.941e-06
323 CARDIOCYTE DIFFERENTIATION 46 96 4.255e-07 6.122e-06
324 CARDIAC CONDUCTION 41 82 4.263e-07 6.122e-06
325 REGULATION OF ORGANELLE ORGANIZATION 359 1178 4.352e-07 6.23e-06
326 REGULATION OF HORMONE LEVELS 164 478 4.491e-07 6.41e-06
327 REGULATION OF DENDRITE MORPHOGENESIS 38 74 4.689e-07 6.632e-06
328 CATION TRANSPORT 254 796 4.68e-07 6.632e-06
329 EPHRIN RECEPTOR SIGNALING PATHWAY 42 85 4.683e-07 6.632e-06
330 NEGATIVE REGULATION OF LOCOMOTION 100 263 4.756e-07 6.706e-06
331 ION TRANSMEMBRANE TRANSPORT 261 822 5.123e-07 7.202e-06
332 DEVELOPMENTAL MATURATION 78 193 5.261e-07 7.373e-06
333 REGULATION OF EMBRYONIC DEVELOPMENT 52 114 5.481e-07 7.658e-06
334 PALLIUM DEVELOPMENT 65 153 5.673e-07 7.903e-06
335 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 62 144 5.87e-07 8.153e-06
336 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 60 138 5.935e-07 8.208e-06
337 ADULT BEHAVIOR 59 135 5.945e-07 8.208e-06
338 CELL SUBSTRATE JUNCTION ASSEMBLY 25 41 6.456e-07 8.862e-06
339 PROSTATE GLAND DEVELOPMENT 25 41 6.456e-07 8.862e-06
340 ARTERY MORPHOGENESIS 29 51 6.696e-07 9.164e-06
341 IMMUNE SYSTEM DEVELOPMENT 193 582 6.764e-07 9.229e-06
342 REGULATION OF MUSCLE TISSUE DEVELOPMENT 48 103 6.8e-07 9.23e-06
343 POSITIVE REGULATION OF CATABOLIC PROCESS 139 395 6.804e-07 9.23e-06
344 RESPONSE TO OXYGEN LEVELS 114 311 6.939e-07 9.386e-06
345 REGULATION OF NEURON DEATH 96 252 7.225e-07 9.745e-06
346 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 65 154 7.502e-07 1.009e-05
347 REGULATION OF AUTOPHAGY 95 249 7.613e-07 1.021e-05
348 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 52 115 7.653e-07 1.023e-05
349 REGULATION OF PROTEIN SECRETION 137 389 7.751e-07 1.03e-05
350 ION HOMEOSTASIS 191 576 7.749e-07 1.03e-05
351 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 35 67 7.768e-07 1.03e-05
352 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 54 121 7.896e-07 1.044e-05
353 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 58 133 8.05e-07 1.061e-05
354 VENTRICULAR SEPTUM DEVELOPMENT 30 54 8.515e-07 1.113e-05
355 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 45 95 8.507e-07 1.113e-05
356 LONG TERM SYNAPTIC POTENTIATION 24 39 8.519e-07 1.113e-05
357 EAR DEVELOPMENT 78 195 8.553e-07 1.115e-05
358 GOLGI VESICLE TRANSPORT 116 319 8.862e-07 1.152e-05
359 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 36 70 8.904e-07 1.154e-05
360 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 46 98 8.934e-07 1.155e-05
361 CELLULAR RESPONSE TO OXYGEN LEVELS 61 143 1.056e-06 1.361e-05
362 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 54 122 1.084e-06 1.391e-05
363 INTERACTION WITH HOST 58 134 1.085e-06 1.391e-05
364 CARDIAC MUSCLE CELL ACTION POTENTIAL 23 37 1.119e-06 1.43e-05
365 CELLULAR RESPONSE TO EXTERNAL STIMULUS 99 264 1.131e-06 1.441e-05
366 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 44 93 1.169e-06 1.486e-05
367 CELLULAR RESPONSE TO LIPID 156 457 1.196e-06 1.516e-05
368 PROTEIN HOMOOLIGOMERIZATION 94 248 1.215e-06 1.536e-05
369 REGULATION OF SYNAPSE ASSEMBLY 39 79 1.225e-06 1.545e-05
370 REGULATION OF JNK CASCADE 66 159 1.263e-06 1.588e-05
371 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 46 99 1.277e-06 1.602e-05
372 CYTOSKELETON ORGANIZATION 263 838 1.322e-06 1.653e-05
373 CEREBRAL CORTEX DEVELOPMENT 48 105 1.363e-06 1.693e-05
374 INTERSPECIES INTERACTION BETWEEN ORGANISMS 214 662 1.365e-06 1.693e-05
375 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 214 662 1.365e-06 1.693e-05
376 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 50 111 1.423e-06 1.762e-05
377 CELL GROWTH 58 135 1.455e-06 1.796e-05
378 NEGATIVE REGULATION OF GROWTH 90 236 1.501e-06 1.848e-05
379 DEVELOPMENTAL CELL GROWTH 38 77 1.689e-06 2.074e-05
380 DIVALENT INORGANIC CATION HOMEOSTASIS 122 343 1.731e-06 2.12e-05
381 RESPONSE TO LIPID 276 888 1.753e-06 2.141e-05
382 NEGATIVE REGULATION OF KINASE ACTIVITY 94 250 1.823e-06 2.22e-05
383 REGULATED EXOCYTOSIS 86 224 1.844e-06 2.24e-05
384 REGULATION OF MUSCLE ORGAN DEVELOPMENT 47 103 1.863e-06 2.257e-05
385 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 21 33 1.897e-06 2.293e-05
386 POSITIVE REGULATION OF AXONOGENESIS 35 69 1.91e-06 2.302e-05
387 REGULATION OF HEART CONTRACTION 85 221 1.939e-06 2.326e-05
388 EYE MORPHOGENESIS 58 136 1.94e-06 2.326e-05
389 REGULATION OF POTASSIUM ION TRANSPORT 40 83 1.966e-06 2.352e-05
390 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 319 1047 1.997e-06 2.383e-05
391 CELLULAR HOMEOSTASIS 217 676 2.006e-06 2.387e-05
392 COLLAGEN FIBRIL ORGANIZATION 23 38 2.181e-06 2.582e-05
393 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 23 38 2.181e-06 2.582e-05
394 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 194 595 2.258e-06 2.66e-05
395 GASTRULATION 64 155 2.253e-06 2.66e-05
396 NITROGEN COMPOUND TRANSPORT 169 507 2.316e-06 2.714e-05
397 IN UTERO EMBRYONIC DEVELOPMENT 112 311 2.314e-06 2.714e-05
398 CANONICAL WNT SIGNALING PATHWAY 44 95 2.4e-06 2.805e-05
399 SKELETAL MUSCLE ORGAN DEVELOPMENT 58 137 2.573e-06 3e-05
400 CARDIAC CHAMBER MORPHOGENESIS 47 104 2.602e-06 3.026e-05
401 AMINOGLYCAN BIOSYNTHETIC PROCESS 48 107 2.646e-06 3.07e-05
402 FORMATION OF PRIMARY GERM LAYER 49 110 2.679e-06 3.1e-05
403 NEURON CELL CELL ADHESION 13 16 2.694e-06 3.111e-05
404 NEURAL CREST CELL MIGRATION 28 51 2.701e-06 3.111e-05
405 GLYCOPROTEIN METABOLIC PROCESS 124 353 2.942e-06 3.38e-05
406 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 88 233 3.1e-06 3.552e-05
407 REGULATION OF PEPTIDE TRANSPORT 95 256 3.107e-06 3.552e-05
408 REGULATION OF MUSCLE CONTRACTION 61 147 3.172e-06 3.618e-05
409 NEPHRON EPITHELIUM DEVELOPMENT 43 93 3.289e-06 3.741e-05
410 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 195 602 3.434e-06 3.897e-05
411 ODONTOGENESIS 47 105 3.606e-06 4.082e-05
412 NOTCH SIGNALING PATHWAY 50 114 3.682e-06 4.158e-05
413 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 27 49 3.701e-06 4.16e-05
414 CARDIAC SEPTUM MORPHOGENESIS 27 49 3.701e-06 4.16e-05
415 DENDRITE DEVELOPMENT 38 79 3.728e-06 4.18e-05
416 REGULATION OF MESENCHYMAL CELL PROLIFERATION 21 34 3.822e-06 4.275e-05
417 REGULATION OF NEURON APOPTOTIC PROCESS 75 192 3.911e-06 4.364e-05
418 HIPPO SIGNALING 18 27 3.928e-06 4.372e-05
419 KIDNEY MORPHOGENESIS 39 82 3.957e-06 4.394e-05
420 METAL ION TRANSPORT 189 582 4.042e-06 4.478e-05
421 REGULATION OF AXON GUIDANCE 23 39 4.092e-06 4.512e-05
422 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 23 39 4.092e-06 4.512e-05
423 REGIONALIZATION 111 311 4.14e-06 4.554e-05
424 POSITIVE REGULATION OF CELL ADHESION 130 376 4.347e-06 4.76e-05
425 REGULATION OF STEM CELL PROLIFERATION 41 88 4.347e-06 4.76e-05
426 POSITIVE REGULATION OF GROWTH 89 238 4.379e-06 4.783e-05
427 RESPONSE TO BMP 43 94 4.643e-06 5.036e-05
428 NEURAL TUBE FORMATION 43 94 4.643e-06 5.036e-05
429 CELLULAR RESPONSE TO BMP STIMULUS 43 94 4.643e-06 5.036e-05
430 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 80 209 4.737e-06 5.126e-05
431 NEUROTRANSMITTER TRANSPORT 63 155 5.011e-06 5.41e-05
432 ACTOMYOSIN STRUCTURE ORGANIZATION 37 77 5.135e-06 5.531e-05
433 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 29 55 5.313e-06 5.683e-05
434 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 29 55 5.313e-06 5.683e-05
435 CELLULAR CHEMICAL HOMEOSTASIS 185 570 5.294e-06 5.683e-05
436 CELLULAR RESPONSE TO STRESS 454 1565 5.739e-06 6.125e-05
437 PROSTATE GLAND GROWTH 10 11 6.186e-06 6.586e-05
438 BONE DEVELOPMENT 63 156 6.427e-06 6.828e-05
439 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 19 30 6.556e-06 6.948e-05
440 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 68 172 6.708e-06 7.094e-05
441 EXOCRINE SYSTEM DEVELOPMENT 25 45 6.943e-06 7.309e-05
442 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 31 61 6.935e-06 7.309e-05
443 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 28 53 7.326e-06 7.677e-05
444 MAMMARY GLAND EPITHELIUM DEVELOPMENT 28 53 7.326e-06 7.677e-05
445 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 21 35 7.363e-06 7.699e-05
446 RENAL TUBULE DEVELOPMENT 37 78 7.492e-06 7.816e-05
447 RESPONSE TO PEPTIDE 137 404 7.661e-06 7.975e-05
448 CIRCULATORY SYSTEM PROCESS 126 366 7.69e-06 7.987e-05
449 PEPTIDYL AMINO ACID MODIFICATION 259 841 7.812e-06 8.096e-05
450 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 56 135 7.983e-06 8.254e-05
451 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 14 19 8.111e-06 8.368e-05
452 EPITHELIAL TO MESENCHYMAL TRANSITION 29 56 8.466e-06 8.715e-05
453 VENTRICULAR SEPTUM MORPHOGENESIS 18 28 8.49e-06 8.721e-05
454 MESONEPHROS DEVELOPMENT 41 90 8.694e-06 8.91e-05
455 REGULATION OF EXOCYTOSIS 72 186 8.77e-06 8.969e-05
456 NEGATIVE REGULATION OF CELL GROWTH 67 170 8.829e-06 9.009e-05
457 VASCULOGENESIS 30 59 9.581e-06 9.755e-05
458 APOPTOTIC SIGNALING PATHWAY 103 289 9.689e-06 9.843e-05
459 EMBRYONIC EYE MORPHOGENESIS 20 33 9.829e-06 9.964e-05
460 RESPONSE TO EXTERNAL STIMULUS 519 1821 1.035e-05 0.0001046
461 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 125 365 1.109e-05 0.0001119
462 INTEGRIN MEDIATED SIGNALING PATHWAY 38 82 1.124e-05 0.0001132
463 REGULATION OF CYTOSKELETON ORGANIZATION 164 502 1.183e-05 0.0001189
464 NEUROMUSCULAR PROCESS 43 97 1.241e-05 0.0001245
465 LUNG ALVEOLUS DEVELOPMENT 23 41 1.3e-05 0.0001301
466 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 61 153 1.436e-05 0.0001434
467 NEGATIVE REGULATION OF CELL CYCLE 144 433 1.44e-05 0.0001434
468 CHONDROCYTE DIFFERENTIATION 30 60 1.472e-05 0.0001464
469 REGULATION OF SODIUM ION TRANSPORT 36 77 1.485e-05 0.0001474
470 REGULATION OF EPITHELIAL CELL MIGRATION 65 166 1.525e-05 0.000151
471 ADULT LOCOMOTORY BEHAVIOR 37 80 1.542e-05 0.0001523
472 CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 49 116 1.603e-05 0.0001581
473 SECOND MESSENGER MEDIATED SIGNALING 63 160 1.668e-05 0.0001641
474 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 15 22 1.718e-05 0.0001683
475 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 15 22 1.718e-05 0.0001683
476 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 32 66 1.738e-05 0.0001688
477 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 18 29 1.728e-05 0.0001688
478 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 32 66 1.738e-05 0.0001688
479 REGULATION OF CARDIAC CONDUCTION 32 66 1.738e-05 0.0001688
480 PEPTIDYL TYROSINE MODIFICATION 71 186 1.757e-05 0.0001703
481 COCHLEA DEVELOPMENT 22 39 1.777e-05 0.0001719
482 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 55 135 1.789e-05 0.0001727
483 WOUND HEALING 154 470 1.81e-05 0.0001744
484 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 20 34 1.841e-05 0.000177
485 REGULATION OF RESPONSE TO STRESS 424 1468 1.875e-05 0.0001799
486 PROTEIN LOCALIZATION TO CELL PERIPHERY 60 151 1.896e-05 0.0001815
487 REGULATION OF BINDING 100 283 1.943e-05 0.0001856
488 OSTEOBLAST DIFFERENTIATION 52 126 1.96e-05 0.0001869
489 POSITIVE REGULATION OF ION TRANSPORT 86 236 1.977e-05 0.0001881
490 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 35 75 2.042e-05 0.0001935
491 SENSORY PERCEPTION OF PAIN 35 75 2.042e-05 0.0001935
492 NEGATIVE REGULATION OF MAPK CASCADE 58 145 2.055e-05 0.0001944
493 LYMPH VESSEL DEVELOPMENT 14 20 2.095e-05 0.0001973
494 AXONAL FASCICULATION 14 20 2.095e-05 0.0001973
495 MUSCLE CONTRACTION 85 233 2.101e-05 0.0001975
496 REGULATION OF RECEPTOR ACTIVITY 49 117 2.113e-05 0.0001978
497 MAMMARY GLAND DEVELOPMENT 49 117 2.113e-05 0.0001978
498 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 166 514 2.144e-05 0.0002003
499 REGULATION OF JUN KINASE ACTIVITY 37 81 2.178e-05 0.0002031
500 DENDRITE MORPHOGENESIS 23 42 2.213e-05 0.0002055
501 REGULATION OF HEART GROWTH 23 42 2.213e-05 0.0002055
502 REGULATION OF ADHERENS JUNCTION ORGANIZATION 26 50 2.234e-05 0.000207
503 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 74 197 2.254e-05 0.0002085
504 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 39 87 2.262e-05 0.0002088
505 SYNAPTIC VESICLE CYCLE 40 90 2.286e-05 0.0002106
506 CELLULAR RESPONSE TO PEPTIDE 97 274 2.359e-05 0.0002169
507 IMMUNE SYSTEM PROCESS 558 1984 2.376e-05 0.0002181
508 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 122 360 2.429e-05 0.0002218
509 RHYTHMIC PROCESS 104 298 2.431e-05 0.0002218
510 IMPORT INTO CELL 21 37 2.428e-05 0.0002218
511 PATTERNING OF BLOOD VESSELS 19 32 2.483e-05 0.0002252
512 SMOOTH MUSCLE TISSUE DEVELOPMENT 13 18 2.481e-05 0.0002252
513 MUSCLE CELL MIGRATION 13 18 2.481e-05 0.0002252
514 POSITIVE REGULATION OF BINDING 52 127 2.541e-05 0.00023
515 RESPONSE TO ESTRADIOL 58 146 2.609e-05 0.0002357
516 ENDOCYTOSIS 164 509 2.76e-05 0.0002489
517 SYNAPTIC SIGNALING 140 424 2.8e-05 0.000252
518 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 28 56 2.816e-05 0.000252
519 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 12 16 2.816e-05 0.000252
520 OUTFLOW TRACT MORPHOGENESIS 28 56 2.816e-05 0.000252
521 CELLULAR RESPONSE TO ALCOHOL 48 115 2.835e-05 0.0002532
522 CARTILAGE MORPHOGENESIS 10 12 2.894e-05 0.0002579
523 HINDBRAIN DEVELOPMENT 55 137 2.94e-05 0.0002616
524 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 11 14 3.003e-05 0.0002667
525 RETINA DEVELOPMENT IN CAMERA TYPE EYE 53 131 3.165e-05 0.0002805
526 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 18 30 3.338e-05 0.0002953
527 RESPONSE TO OXIDATIVE STRESS 119 352 3.429e-05 0.0003028
528 RESPONSE TO INORGANIC SUBSTANCE 155 479 3.537e-05 0.0003117
529 PROTEIN COMPLEX SUBUNIT ORGANIZATION 437 1527 3.596e-05 0.0003163
530 VACUOLAR TRANSPORT 90 253 3.704e-05 0.0003247
531 REGULATION OF CELL JUNCTION ASSEMBLY 32 68 3.706e-05 0.0003247
532 REGULATION OF ANION TRANSPORT 55 138 3.742e-05 0.0003273
533 CELL CYCLE ARREST 60 154 3.782e-05 0.0003301
534 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 15 23 3.825e-05 0.0003333
535 CARDIAC MUSCLE CELL DIFFERENTIATION 34 74 3.988e-05 0.0003468
536 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 74 200 4.062e-05 0.0003526
537 PROTEIN OLIGOMERIZATION 142 434 4.073e-05 0.0003529
538 CAMERA TYPE EYE MORPHOGENESIS 43 101 4.121e-05 0.0003564
539 NEGATIVE REGULATION OF MOLECULAR FUNCTION 318 1079 4.16e-05 0.0003591
540 MEMORY 42 98 4.175e-05 0.0003598
541 POSITIVE REGULATION OF ORGAN GROWTH 21 38 4.185e-05 0.00036
542 ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 93 264 4.256e-05 0.0003647
543 EPITHELIAL CELL PROLIFERATION 39 89 4.253e-05 0.0003647
544 ACTIN FILAMENT ORGANIZATION 66 174 4.287e-05 0.0003666
545 NEGATIVE REGULATION OF NEURON DEATH 65 171 4.523e-05 0.0003854
546 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 65 171 4.523e-05 0.0003854
547 VESICLE LOCALIZATION 81 224 4.628e-05 0.0003931
548 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 75 204 4.63e-05 0.0003931
549 POSITIVE REGULATION OF CHEMOTAXIS 49 120 4.664e-05 0.0003953
550 REGULATION OF CELL SHAPE 55 139 4.74e-05 0.000401
551 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 48 117 4.812e-05 0.0004064
552 GLOMERULUS DEVELOPMENT 25 49 4.856e-05 0.0004093
553 CELL ACTIVATION 179 568 4.913e-05 0.0004128
554 REGULATION OF ION HOMEOSTASIS 74 201 4.915e-05 0.0004128
555 REGULATION OF MEMBRANE DEPOLARIZATION 22 41 5.063e-05 0.0004237
556 AORTA DEVELOPMENT 22 41 5.063e-05 0.0004237
557 ORGANIC ANION TRANSPORT 128 387 5.54e-05 0.0004628
558 POSITIVE REGULATION OF AUTOPHAGY 34 75 5.601e-05 0.0004671
559 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 276 926 5.706e-05 0.0004745
560 MULTICELLULAR ORGANISM METABOLIC PROCESS 40 93 5.711e-05 0.0004745
561 POSITIVE REGULATION OF AXON EXTENSION 20 36 5.754e-05 0.0004773
562 INOSITOL LIPID MEDIATED SIGNALING 50 124 5.791e-05 0.0004794
563 REGULATION OF CELL CYCLE 282 949 6.012e-05 0.0004968
564 MESODERM DEVELOPMENT 48 118 6.215e-05 0.0005127
565 REGULATION OF CALCIUM ION TRANSPORT 76 209 6.309e-05 0.0005196
566 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 29 61 6.71e-05 0.0005506
567 POSITIVE REGULATION OF STEM CELL PROLIFERATION 29 61 6.71e-05 0.0005506
568 REGULATION OF PHOSPHOLIPASE C ACTIVITY 21 39 6.995e-05 0.000572
569 NEGATIVE CHEMOTAXIS 21 39 6.995e-05 0.000572
570 REGULATION OF PHOSPHOLIPASE ACTIVITY 30 64 7.034e-05 0.0005732
571 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 30 64 7.034e-05 0.0005732
572 MONOVALENT INORGANIC CATION TRANSPORT 141 435 7.131e-05 0.0005801
573 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 42 100 7.351e-05 0.0005969
574 ANION TRANSPORT 161 507 7.511e-05 0.0006089
575 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 40 94 7.625e-05 0.000616
576 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II 40 94 7.625e-05 0.000616
577 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 35 79 7.848e-05 0.0006329
578 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 15 24 7.902e-05 0.0006361
579 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 26 53 8.154e-05 0.0006541
580 CELLULAR RESPONSE TO AMINO ACID STIMULUS 26 53 8.154e-05 0.0006541
581 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 17 29 8.357e-05 0.000667
582 REGULATION OF VACUOLAR TRANSPORT 17 29 8.357e-05 0.000667
583 STEM CELL DIVISION 17 29 8.357e-05 0.000667
584 CELL COMMUNICATION BY ELECTRICAL COUPLING 11 15 8.769e-05 0.0006963
585 VENOUS BLOOD VESSEL DEVELOPMENT 11 15 8.769e-05 0.0006963
586 EPITHELIAL CELL MATURATION 11 15 8.769e-05 0.0006963
587 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 28 59 9.264e-05 0.0007343
588 LUNG MORPHOGENESIS 23 45 9.329e-05 0.000737
589 SPROUTING ANGIOGENESIS 23 45 9.329e-05 0.000737
590 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 50 126 9.389e-05 0.0007405
591 CARBOHYDRATE METABOLIC PROCESS 203 662 9.604e-05 0.0007561
592 CORONARY VASCULATURE DEVELOPMENT 20 37 9.667e-05 0.0007594
593 CARDIAC VENTRICLE MORPHOGENESIS 29 62 9.695e-05 0.0007594
594 REGULATION OF SMOOTHENED SIGNALING PATHWAY 29 62 9.695e-05 0.0007594
595 ENDOCRINE SYSTEM DEVELOPMENT 49 123 9.789e-05 0.0007655
596 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 41 98 9.888e-05 0.0007719
597 INTRINSIC APOPTOTIC SIGNALING PATHWAY 58 152 9.983e-05 0.0007781
598 RESPONSE TO INSULIN 74 205 0.0001024 0.000797
599 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 24 48 0.0001037 0.0008026
600 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 24 48 0.0001037 0.0008026
601 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 24 48 0.0001037 0.0008026
602 PROTEIN LOCALIZATION TO CELL SURFACE 14 22 0.0001039 0.0008034
603 EMBRYONIC PLACENTA DEVELOPMENT 36 83 0.0001067 0.0008235
604 REGULATION OF BMP SIGNALING PATHWAY 34 77 0.0001071 0.0008247
605 METANEPHRIC NEPHRON DEVELOPMENT 18 32 0.0001087 0.0008357
606 POSITIVE REGULATION OF HEART GROWTH 16 27 0.0001133 0.000867
607 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 16 27 0.0001133 0.000867
608 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 16 27 0.0001133 0.000867
609 AMINO ACID TRANSPORT 49 124 0.000124 0.0009475
610 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 22 43 0.0001294 0.0009842
611 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 22 43 0.0001294 0.0009842
612 CEREBRAL CORTEX CELL MIGRATION 22 43 0.0001294 0.0009842
613 REGULATION OF GLUCOSE IMPORT 28 60 0.0001336 0.001014
614 ACTIN FILAMENT BASED MOVEMENT 39 93 0.0001361 0.001031
615 REGULATION OF GLIOGENESIS 38 90 0.0001389 0.001051
616 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 37 87 0.0001414 0.001054
617 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 37 87 0.0001414 0.001054
618 REGULATION OF FATTY ACID METABOLIC PROCESS 37 87 0.0001414 0.001054
619 VIRAL ENTRY INTO HOST CELL 37 87 0.0001414 0.001054
620 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 37 87 0.0001414 0.001054
621 MESODERM MORPHOGENESIS 30 66 0.0001416 0.001054
622 MOVEMENT IN HOST ENVIRONMENT 37 87 0.0001414 0.001054
623 ENTRY INTO HOST 37 87 0.0001414 0.001054
624 ENTRY INTO HOST CELL 37 87 0.0001414 0.001054
625 LENS DEVELOPMENT IN CAMERA TYPE EYE 30 66 0.0001416 0.001054
626 NEGATIVE REGULATION OF OSSIFICATION 31 69 0.000144 0.00107
627 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 33 75 0.000146 0.001083
628 RESPONSE TO AMINO ACID 45 112 0.0001463 0.001084
629 REGULATION OF BODY FLUID LEVELS 159 506 0.0001476 0.001092
630 REGULATION OF LIPID BIOSYNTHETIC PROCESS 50 128 0.0001492 0.0011
631 MUSCLE CELL DEVELOPMENT 50 128 0.0001492 0.0011
632 EPITHELIAL CELL APOPTOTIC PROCESS 15 25 0.0001531 0.001127
633 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 24 49 0.0001566 0.001151
634 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 20 38 0.0001576 0.001156
635 PLACENTA DEVELOPMENT 53 138 0.0001605 0.001176
636 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 80 228 0.0001628 0.00119
637 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 42 103 0.000163 0.00119
638 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 52 135 0.0001689 0.001232
639 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 12 18 0.0001737 0.001265
640 CRANIAL SKELETAL SYSTEM DEVELOPMENT 26 55 0.0001768 0.001285
641 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 68 188 0.0001785 0.001293
642 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 46 116 0.0001787 0.001293
643 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 46 116 0.0001787 0.001293
644 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 21 41 0.0001798 0.001299
645 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 116 354 0.0001839 0.001327
646 HEART PROCESS 36 85 0.000191 0.001376
647 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 44 110 0.0001941 0.001394
648 JNK CASCADE 35 82 0.0001942 0.001394
649 ORGANELLE LOCALIZATION 133 415 0.0001959 0.001405
650 BONE MORPHOGENESIS 34 79 0.0001966 0.001408
651 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 33 76 0.0001983 0.001416
652 PANCREAS DEVELOPMENT 32 73 0.000199 0.001416
653 MUSCLE ORGAN MORPHOGENESIS 31 70 0.0001987 0.001416
654 REGULATION OF PLASMA MEMBRANE ORGANIZATION 32 73 0.000199 0.001416
655 NEGATIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 43 107 0.0002019 0.001435
656 PROSTATE GLAND MORPHOGENESIS 14 23 0.0002061 0.001462
657 REGULATION OF ENDOCYTOSIS 71 199 0.0002096 0.001484
658 RESPONSE TO EXTRACELLULAR STIMULUS 140 441 0.0002167 0.001532
659 SEMAPHORIN PLEXIN SIGNALING PATHWAY 19 36 0.0002187 0.001542
660 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 19 36 0.0002187 0.001542
661 REGULATION OF ACTIN FILAMENT LENGTH 58 156 0.0002254 0.001587
662 AMINOGLYCAN METABOLIC PROCESS 61 166 0.0002286 0.001607
663 RESPONSE TO CORTICOSTEROID 64 176 0.0002291 0.001608
664 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 39 95 0.0002324 0.001624
665 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 24 50 0.0002321 0.001624
666 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 54 143 0.0002318 0.001624
667 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 25 53 0.0002444 0.0017
668 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 25 53 0.0002444 0.0017
669 MESONEPHRIC TUBULE MORPHOGENESIS 25 53 0.0002444 0.0017
670 POST EMBRYONIC DEVELOPMENT 37 89 0.0002462 0.00171
671 ASTROCYTE DIFFERENTIATION 20 39 0.0002498 0.001732
672 REGULATION OF DENDRITIC SPINE DEVELOPMENT 26 56 0.0002542 0.00176
673 GLUCOSE HOMEOSTASIS 62 170 0.0002592 0.001787
674 CARBOHYDRATE HOMEOSTASIS 62 170 0.0002592 0.001787
675 ACTIVATION OF MAPK ACTIVITY 52 137 0.0002587 0.001787
676 PROTEIN HOMOTETRAMERIZATION 27 59 0.0002616 0.001801
677 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 34 80 0.0002628 0.001803
678 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 34 80 0.0002628 0.001803
679 PHOSPHOLIPID METABOLIC PROCESS 118 364 0.0002638 0.001808
680 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 10 14 0.0002674 0.001824
681 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 28 62 0.0002668 0.001824
682 CONVERGENT EXTENSION 10 14 0.0002674 0.001824
683 NEGATIVE REGULATION OF AXONOGENESIS 29 65 0.00027 0.00184
684 CHONDROCYTE DEVELOPMENT 13 21 0.000276 0.001875
685 NEGATIVE REGULATION OF ORGAN GROWTH 13 21 0.000276 0.001875
686 POSITIVE REGULATION OF DNA BINDING 21 42 0.0002775 0.001882
687 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 15 26 0.0002806 0.0019
688 ANTERIOR POSTERIOR PATTERN SPECIFICATION 69 194 0.0002831 0.001914
689 VESICLE ORGANIZATION 94 280 0.0002845 0.001921
690 CELL MATURATION 50 131 0.0002882 0.001943
691 POTASSIUM ION TRANSPORT 57 154 0.0002906 0.001957
692 RESPONSE TO ESTROGEN 76 218 0.0002927 0.001965
693 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 76 218 0.0002927 0.001965
694 RESPONSE TO CALCIUM ION 45 115 0.0002975 0.001995
695 ENDOTHELIAL CELL DEVELOPMENT 22 45 0.0003015 0.002019
696 POSITIVE REGULATION OF SODIUM ION TRANSPORT 18 34 0.0003038 0.002022
697 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 18 34 0.0003038 0.002022
698 HEART VALVE DEVELOPMENT 18 34 0.0003038 0.002022
699 CAMP METABOLIC PROCESS 18 34 0.0003038 0.002022
700 EAR MORPHOGENESIS 44 112 0.0003117 0.002072
701 CELL ADHESION MEDIATED BY INTEGRIN 9 12 0.0003125 0.002074
702 CALCIUM MEDIATED SIGNALING 37 90 0.0003211 0.002125
703 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 37 90 0.0003211 0.002125
704 TISSUE REMODELING 36 87 0.0003307 0.002186
705 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 24 51 0.000338 0.002231
706 SPINAL CORD DEVELOPMENT 42 106 0.0003408 0.00224
707 SYNAPTIC VESICLE LOCALIZATION 42 106 0.0003408 0.00224
708 REGULATION OF FAT CELL DIFFERENTIATION 42 106 0.0003408 0.00224
709 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 19 37 0.0003475 0.002274
710 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 19 37 0.0003475 0.002274
711 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 19 37 0.0003475 0.002274
712 LEUKOCYTE DIFFERENTIATION 97 292 0.0003493 0.002283
713 MONOSACCHARIDE TRANSPORT 25 54 0.0003507 0.002289
714 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 16 29 0.0003538 0.002306
715 REGULATION OF CALCIUM ION IMPORT 41 103 0.0003558 0.002315
716 PROTEIN TARGETING 129 406 0.0003601 0.002334
717 MYOTUBE DIFFERENTIATION 26 57 0.0003601 0.002334
718 APOPTOTIC MITOCHONDRIAL CHANGES 26 57 0.0003601 0.002334
719 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 12 19 0.000367 0.002358
720 STEM CELL PROLIFERATION 27 60 0.0003663 0.002358
721 ENTEROENDOCRINE CELL DIFFERENTIATION 12 19 0.000367 0.002358
722 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 12 19 0.000367 0.002358
723 REGULATION OF LONG TERM SYNAPTIC POTENTIATION 12 19 0.000367 0.002358
724 OLIGODENDROCYTE DIFFERENTIATION 27 60 0.0003663 0.002358
725 POSITIVE REGULATION OF JUN KINASE ACTIVITY 28 63 0.0003698 0.002373
726 METENCEPHALON DEVELOPMENT 40 100 0.0003708 0.002376
727 NEGATIVE REGULATION OF CELL ADHESION 77 223 0.0003746 0.002398
728 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 59 162 0.0003754 0.0024
729 MYELOID CELL DIFFERENTIATION 67 189 0.000382 0.002438
730 MAMMARY GLAND MORPHOGENESIS 20 40 0.000386 0.002447
731 POSITIVE REGULATION OF CELL MATRIX ADHESION 20 40 0.000386 0.002447
732 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 14 24 0.000384 0.002447
733 ENDOCRINE PANCREAS DEVELOPMENT 20 40 0.000386 0.002447
734 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 20 40 0.000386 0.002447
735 SALIVARY GLAND DEVELOPMENT 17 32 0.0004223 0.002666
736 CELLULAR RESPONSE TO INSULIN STIMULUS 54 146 0.0004217 0.002666
737 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 17 32 0.0004223 0.002666
738 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 98 297 0.0004251 0.002676
739 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 57 156 0.0004249 0.002676
740 REGULATION OF CATION CHANNEL ACTIVITY 36 88 0.00043 0.002704
741 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 22 46 0.000446 0.002801
742 REGULATION OF PROTEIN STABILITY 76 221 0.0004672 0.00293
743 NON CANONICAL WNT SIGNALING PATHWAY 52 140 0.000475 0.002974
744 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 11 17 0.000483 0.003009
745 ESTABLISHMENT OF TISSUE POLARITY 11 17 0.000483 0.003009
746 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 11 17 0.000483 0.003009
747 NEGATIVE REGULATION OF ANOIKIS 11 17 0.000483 0.003009
748 NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 18 35 0.0004839 0.00301
749 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 15 27 0.0004897 0.003034
750 EXCITATORY POSTSYNAPTIC POTENTIAL 15 27 0.0004897 0.003034
751 REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 15 27 0.0004897 0.003034
752 NEGATIVE REGULATION OF PROTEIN POLYMERIZATION 25 55 0.0004957 0.003067
753 REGULATION OF MEMBRANE PERMEABILITY 30 70 0.0004976 0.003071
754 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 30 70 0.0004976 0.003071
755 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 75 218 0.0004998 0.003081
756 NEURON FATE COMMITMENT 29 67 0.0005032 0.003097
757 PROTEIN TARGETING TO MEMBRANE 57 157 0.0005111 0.003141
758 SOMATIC STEM CELL DIVISION 13 22 0.0005246 0.00322
759 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 91 274 0.000526 0.003225
760 GLYCOSYLATION 89 267 0.0005269 0.003226
761 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 37 92 0.0005341 0.003265
762 NEGATIVE REGULATION OF AXON EXTENSION 19 38 0.0005375 0.003278
763 MESENCHYME MORPHOGENESIS 19 38 0.0005375 0.003278
764 REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 61 171 0.0005647 0.003435
765 REGULATION OF RESPONSE TO NUTRIENT LEVELS 61 171 0.0005647 0.003435
766 NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 49 131 0.0005662 0.003439
767 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 52 141 0.0005768 0.003499
768 SMOOTH MUSCLE CELL DIFFERENTIATION 16 30 0.0005877 0.003528
769 NEURON MATURATION 16 30 0.0005877 0.003528
770 REGULATION OF NEURON MIGRATION 16 30 0.0005877 0.003528
771 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 16 30 0.0005877 0.003528
772 ESTABLISHMENT OF ENDOTHELIAL BARRIER 16 30 0.0005877 0.003528
773 OSTEOCLAST DIFFERENTIATION 16 30 0.0005877 0.003528
774 REGULATION OF MEMBRANE REPOLARIZATION 16 30 0.0005877 0.003528
775 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 16 30 0.0005877 0.003528
776 POST GOLGI VESICLE MEDIATED TRANSPORT 34 83 0.0005952 0.003569
777 RESPONSE TO CARBOHYDRATE 60 168 0.0006025 0.003604
778 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 60 168 0.0006025 0.003604
779 CELLULAR RESPONSE TO MECHANICAL STIMULUS 33 80 0.0006143 0.003669
780 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 21 44 0.000619 0.003693
781 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 39 99 0.0006237 0.003706
782 LIPID PHOSPHORYLATION 39 99 0.0006237 0.003706
783 INORGANIC ION TRANSMEMBRANE TRANSPORT 176 583 0.0006234 0.003706
784 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 10 15 0.0006267 0.00371
785 REGULATION OF PROTEIN CATABOLIC PROCESS 124 393 0.0006261 0.00371
786 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 10 15 0.0006267 0.00371
787 POSITIVE REGULATION OF GLIOGENESIS 22 47 0.0006474 0.003828
788 CELL CELL JUNCTION ASSEMBLY 31 74 0.0006486 0.00383
789 RESPONSE TO KETONE 64 182 0.0006499 0.003833
790 LENS FIBER CELL DIFFERENTIATION 14 25 0.000678 0.003943
791 KERATAN SULFATE METABOLIC PROCESS 17 33 0.0006747 0.003943
792 MEMBRANE ASSEMBLY 14 25 0.000678 0.003943
793 CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 46 122 0.0006723 0.003943
794 CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT 14 25 0.000678 0.003943
795 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 75 220 0.0006752 0.003943
796 VIRAL LIFE CYCLE 95 290 0.0006752 0.003943
797 POSITIVE REGULATION OF LIPID CATABOLIC PROCESS 14 25 0.000678 0.003943
798 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 17 33 0.0006747 0.003943
799 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 14 25 0.000678 0.003943
800 RESPONSE TO HYDROGEN PEROXIDE 42 109 0.0006754 0.003943
801 FOREBRAIN CELL MIGRATION 27 62 0.000691 0.004009
802 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 27 62 0.000691 0.004009
803 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 55 152 0.0006955 0.00403
804 REGULATION OF GLUCOSE METABOLIC PROCESS 41 106 0.0007109 0.004114
805 EMBRYONIC HEMOPOIESIS 12 20 0.0007145 0.004125
806 MYOBLAST FUSION 12 20 0.0007145 0.004125
807 SEX DIFFERENTIATION 88 266 0.0007379 0.004255
808 POSITIVE REGULATION OF OSSIFICATION 34 84 0.0007689 0.004428
809 ORGANOPHOSPHATE METABOLIC PROCESS 256 885 0.0007711 0.004435
810 REGULATION OF GLUCOSE TRANSPORT 39 100 0.0007853 0.004511
811 REGULATION OF PROTEIN POLYMERIZATION 61 173 0.0007929 0.004549
812 SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION 9 13 0.0007954 0.004558
813 CALCIUM ION REGULATED EXOCYTOSIS 33 81 0.0007973 0.004563
814 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 117 370 0.0008001 0.004573
815 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 19 39 0.0008107 0.004629
816 KERATAN SULFATE BIOSYNTHETIC PROCESS 15 28 0.0008186 0.004639
817 REGULATION OF FATTY ACID OXIDATION 15 28 0.0008186 0.004639
818 MORPHOGENESIS OF A POLARIZED EPITHELIUM 15 28 0.0008186 0.004639
819 MAMMARY GLAND DUCT MORPHOGENESIS 15 28 0.0008186 0.004639
820 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 58 163 0.0008157 0.004639
821 SYNCYTIUM FORMATION 15 28 0.0008186 0.004639
822 HORMONE TRANSPORT 32 78 0.0008247 0.004657
823 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 32 78 0.0008247 0.004657
824 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 38 97 0.0008241 0.004657
825 MULTI ORGANISM BEHAVIOR 31 75 0.0008509 0.004799
826 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 20 42 0.0008597 0.004843
827 REGULATION OF REGULATED SECRETORY PATHWAY 48 130 0.000891 0.005013
828 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 21 45 0.0008968 0.005028
829 PROTEASOMAL PROTEIN CATABOLIC PROCESS 89 271 0.0008949 0.005028
830 ENDOCHONDRAL BONE MORPHOGENESIS 21 45 0.0008968 0.005028
831 CELLULAR RESPONSE TO OXIDATIVE STRESS 64 184 0.0008987 0.005032
832 POSITIVE REGULATION OF LIPASE ACTIVITY 28 66 0.0009164 0.005119
833 REGULATION OF CARDIAC MUSCLE CONTRACTION 28 66 0.0009164 0.005119
834 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 22 48 0.0009231 0.005138
835 POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 22 48 0.0009231 0.005138
836 POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS 22 48 0.0009231 0.005138
837 NEUROMUSCULAR PROCESS CONTROLLING BALANCE 23 51 0.0009397 0.005205
838 NEGATIVE REGULATION OF CHEMOTAXIS 23 51 0.0009397 0.005205
839 RESPONSE TO AUDITORY STIMULUS 13 23 0.0009386 0.005205
840 INNERVATION 13 23 0.0009386 0.005205
841 REGULATION OF SMOOTH MUSCLE CONTRACTION 26 60 0.0009428 0.005216
842 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 53 147 0.0009462 0.005229
843 CARDIAC MUSCLE TISSUE MORPHOGENESIS 24 54 0.0009478 0.005231
844 DIVALENT INORGANIC CATION TRANSPORT 88 268 0.0009583 0.005283
845 PROTEIN COMPLEX BIOGENESIS 320 1132 0.0009684 0.005305
846 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 11 18 0.0009691 0.005305
847 PERICARDIUM DEVELOPMENT 11 18 0.0009691 0.005305
848 KIDNEY MESENCHYME DEVELOPMENT 11 18 0.0009691 0.005305
849 UTERUS DEVELOPMENT 11 18 0.0009691 0.005305
850 PROTEIN COMPLEX ASSEMBLY 320 1132 0.0009684 0.005305
851 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 8 11 0.0009748 0.005317
852 HETEROCHROMATIN ORGANIZATION 8 11 0.0009748 0.005317
853 PROSTATE GLANDULAR ACINUS DEVELOPMENT 8 11 0.0009748 0.005317
854 PROTEIN O LINKED GLYCOSYLATION 39 101 0.0009829 0.005355
855 RESPONSE TO VITAMIN 38 98 0.001034 0.005629
856 ANION TRANSMEMBRANE TRANSPORT 83 251 0.00104 0.005651
857 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 17 34 0.001046 0.00567
858 CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER 17 34 0.001046 0.00567
859 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 111 351 0.001068 0.005786
860 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 48 131 0.001079 0.005838
861 CARBOHYDRATE TRANSPORT 37 95 0.001087 0.005876
862 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 18 37 0.00113 0.006077
863 MYOBLAST DIFFERENTIATION 18 37 0.00113 0.006077
864 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 18 37 0.00113 0.006077
865 AXON EXTENSION 18 37 0.00113 0.006077
866 HIPPOCAMPUS DEVELOPMENT 30 73 0.001144 0.006119
867 MESODERMAL CELL DIFFERENTIATION 14 26 0.001142 0.006119
868 CELLULAR RESPONSE TO KETONE 30 73 0.001144 0.006119
869 HEART GROWTH 14 26 0.001142 0.006119
870 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 30 73 0.001144 0.006119
871 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 47 128 0.001148 0.006131
872 LEUKOCYTE MIGRATION 85 259 0.001177 0.006278
873 REGULATION OF CELL PROJECTION ASSEMBLY 55 155 0.001179 0.006278
874 NEGATIVE REGULATION OF CATABOLIC PROCESS 69 203 0.001179 0.006278
875 POSITIVE REGULATION OF SECRETION 116 370 0.001183 0.006291
876 FORELIMB MORPHOGENESIS 19 40 0.001195 0.006348
877 REGULATION OF ERK1 AND ERK2 CASCADE 79 238 0.001197 0.006352
878 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 119 381 0.001199 0.006356
879 LEUKOCYTE ACTIVATION 128 414 0.001232 0.006524
880 MORPHOGENESIS OF AN EPITHELIAL SHEET 20 43 0.001243 0.006558
881 REGULATION OF NEUROTRANSMITTER TRANSPORT 27 64 0.001242 0.006558
882 REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 20 43 0.001243 0.006558
883 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 66 193 0.001248 0.006577
884 REGULATION OF HEART RATE 34 86 0.001254 0.006592
885 REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 34 86 0.001254 0.006592
886 MEMBRANE DEPOLARIZATION 26 61 0.001267 0.006647
887 EMBRYONIC DIGIT MORPHOGENESIS 26 61 0.001267 0.006647
888 VENTRAL SPINAL CORD DEVELOPMENT 21 46 0.001275 0.006661
889 PEPTIDYL THREONINE MODIFICATION 21 46 0.001275 0.006661
890 INTRASPECIES INTERACTION BETWEEN ORGANISMS 21 46 0.001275 0.006661
891 SOCIAL BEHAVIOR 21 46 0.001275 0.006661
892 PHOSPHOLIPID BIOSYNTHETIC PROCESS 78 235 0.001283 0.00669
893 PEPTIDE SECRETION 25 58 0.001286 0.006693
894 PROTEOGLYCAN BIOSYNTHETIC PROCESS 25 58 0.001286 0.006693
895 STRIATED MUSCLE CONTRACTION 38 99 0.00129 0.006707
896 NEGATIVE REGULATION OF PEPTIDE SECRETION 22 49 0.001294 0.006716
897 REGULATION OF KIDNEY DEVELOPMENT 24 55 0.001298 0.006716
898 REGULATION OF GLIAL CELL PROLIFERATION 12 21 0.001299 0.006716
899 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 12 21 0.001299 0.006716
900 LOCALIZATION WITHIN MEMBRANE 45 122 0.001298 0.006716
901 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 10 16 0.001307 0.006726
902 REGULATION OF CLATHRIN MEDIATED ENDOCYTOSIS 10 16 0.001307 0.006726
903 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 10 16 0.001307 0.006726
904 REGULATION OF FATTY ACID BETA OXIDATION 10 16 0.001307 0.006726
905 PROTEOGLYCAN METABOLIC PROCESS 33 83 0.001311 0.006733
906 REGULATION OF LIPASE ACTIVITY 33 83 0.001311 0.006733
907 CARDIAC MUSCLE CELL CONTRACTION 15 29 0.001317 0.006747
908 REGULATION OF PROTEIN IMPORT 63 183 0.001316 0.006747
909 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 41 109 0.001349 0.006906
910 MYELOID LEUKOCYTE DIFFERENTIATION 37 96 0.00136 0.006954
911 REGULATION OF PROTEIN COMPLEX ASSEMBLY 117 375 0.001367 0.006984
912 CATABOLIC PROCESS 484 1773 0.001389 0.007087
913 AGING 86 264 0.001417 0.007214
914 LIPID LOCALIZATION 86 264 0.001417 0.007214
915 FAT CELL DIFFERENTIATION 40 106 0.001429 0.007266
916 REGULATION OF DNA BINDING 36 93 0.001432 0.007276
917 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 16 32 0.001461 0.007407
918 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 16 32 0.001461 0.007407
919 FEMALE SEX DIFFERENTIATION 43 116 0.001465 0.00742
920 RETROGRADE TRANSPORT ENDOSOME TO GOLGI 30 74 0.001482 0.007495
921 MIDBRAIN DEVELOPMENT 35 90 0.001507 0.007613
922 ORGANIC ACID TRANSMEMBRANE TRANSPORT 39 103 0.001512 0.007623
923 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 39 103 0.001512 0.007623
924 ORGANIC ACID TRANSPORT 85 261 0.001518 0.007642
925 RAS PROTEIN SIGNAL TRANSDUCTION 51 143 0.001534 0.007718
926 ADHERENS JUNCTION ORGANIZATION 29 71 0.001537 0.007723
927 REGULATION OF GLYCOGEN METABOLIC PROCESS 17 35 0.001576 0.007902
928 CLATHRIN MEDIATED ENDOCYTOSIS 17 35 0.001576 0.007902
929 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 13 24 0.001594 0.007966
930 RESPONSE TO METAL ION 105 333 0.001593 0.007966
931 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 13 24 0.001594 0.007966
932 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 38 100 0.001599 0.007985
933 TISSUE MIGRATION 33 84 0.001662 0.008279
934 CYTOKINESIS 33 84 0.001662 0.008279
935 EMBRYONIC HEART TUBE MORPHOGENESIS 26 62 0.001683 0.008377
936 AMIDE TRANSPORT 37 97 0.00169 0.008395
937 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 37 97 0.00169 0.008395
938 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 19 41 0.001724 0.008543
939 RECEPTOR CLUSTERING 19 41 0.001724 0.008543
940 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 14 0.001746 0.008587
941 REGULATION OF FIBROBLAST PROLIFERATION 32 81 0.001741 0.008587
942 POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 9 14 0.001746 0.008587
943 METANEPHRIC MESENCHYME DEVELOPMENT 9 14 0.001746 0.008587
944 POSITIVE REGULATION OF FATTY ACID OXIDATION 9 14 0.001746 0.008587
945 CELLULAR RESPONSE TO VITAMIN D 9 14 0.001746 0.008587
946 DETECTION OF CALCIUM ION 9 14 0.001746 0.008587
947 IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 24 56 0.001753 0.008597
948 REGULATION OF SEQUESTERING OF CALCIUM ION 40 107 0.001753 0.008597
949 PLATELET DEGRANULATION 40 107 0.001753 0.008597
950 NEURON PROJECTION EXTENSION 23 53 0.001775 0.008677
951 REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 23 53 0.001775 0.008677
952 SKELETAL MUSCLE CELL DIFFERENTIATION 23 53 0.001775 0.008677
953 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 22 50 0.001786 0.008683
954 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 22 50 0.001786 0.008683
955 SPECIFICATION OF SYMMETRY 43 117 0.00178 0.008683
956 VISUAL BEHAVIOR 22 50 0.001786 0.008683
957 PROTEIN K48 LINKED UBIQUITINATION 21 47 0.001783 0.008683
958 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 11 19 0.001797 0.00871
959 MUSCLE CELL PROLIFERATION 11 19 0.001797 0.00871
960 MACROPHAGE DIFFERENTIATION 11 19 0.001797 0.00871
961 REGENERATION 56 161 0.001811 0.008768
962 SOMITE DEVELOPMENT 31 78 0.001822 0.008813
963 GLYCEROLIPID METABOLIC PROCESS 111 356 0.001827 0.008826
964 NEGATIVE REGULATION OF AXON GUIDANCE 14 27 0.001844 0.008861
965 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 27 0.001844 0.008861
966 REGULATION OF CATENIN IMPORT INTO NUCLEUS 14 27 0.001844 0.008861
967 SUBSTRATE DEPENDENT CELL MIGRATION 14 27 0.001844 0.008861
968 AXIS ELONGATION 14 27 0.001844 0.008861
969 HOMEOSTASIS OF NUMBER OF CELLS 60 175 0.001883 0.009041
970 REGULATION OF ENDOTHELIAL CELL MIGRATION 42 114 0.001893 0.009081
971 PROTEIN N LINKED GLYCOSYLATION 30 75 0.001903 0.009109
972 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 30 75 0.001903 0.009109
973 REGULATION OF DEPHOSPHORYLATION 55 158 0.001938 0.009268
974 SMOOTHENED SIGNALING PATHWAY 29 72 0.001983 0.009464
975 PEPTIDE TRANSPORT 29 72 0.001983 0.009464
976 PROTEIN STABILIZATION 47 131 0.001994 0.009506
977 POSITIVE REGULATION OF CELL GROWTH 52 148 0.002016 0.009604
978 MEMBRANE BIOGENESIS 15 30 0.002046 0.009712
979 POSITIVE REGULATION OF VIRAL GENOME REPLICATION 15 30 0.002046 0.009712
980 RESPONSE TO EPIDERMAL GROWTH FACTOR 15 30 0.002046 0.009712
981 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 28 69 0.002062 0.009781
982 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 37 98 0.002089 0.009896
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 630 1737 1.441e-31 1.339e-28
2 MACROMOLECULAR COMPLEX BINDING 509 1399 9.752e-26 4.53e-23
3 PROTEIN COMPLEX BINDING 360 935 4.631e-23 1.434e-20
4 CYTOSKELETAL PROTEIN BINDING 313 819 1.388e-19 3.223e-17
5 KINASE BINDING 246 606 2.186e-19 4.061e-17
6 PROTEIN KINASE ACTIVITY 246 640 5.839e-16 8.778e-14
7 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 146 328 6.614e-16 8.778e-14
8 ACTIN BINDING 167 393 1.102e-15 1.28e-13
9 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 240 629 3.559e-15 3.674e-13
10 KINASE ACTIVITY 303 842 7.435e-15 6.907e-13
11 MOLECULAR FUNCTION REGULATOR 450 1353 1.038e-14 8.261e-13
12 IDENTICAL PROTEIN BINDING 409 1209 1.067e-14 8.261e-13
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 138 315 1.934e-14 1.382e-12
14 CELL ADHESION MOLECULE BINDING 93 186 2.745e-14 1.822e-12
15 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 106 226 1.02e-13 6.315e-12
16 PROTEIN DOMAIN SPECIFIC BINDING 233 624 1.366e-13 7.931e-12
17 INTEGRIN BINDING 60 105 6.348e-13 3.469e-11
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 390 1199 2.227e-11 1.089e-09
19 RECEPTOR BINDING 467 1476 2.177e-11 1.089e-09
20 PROTEIN SERINE THREONINE KINASE ACTIVITY 170 445 3.514e-11 1.632e-09
21 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 328 992 1.199e-10 5.303e-09
22 RIBONUCLEOTIDE BINDING 566 1860 1.804e-10 7.619e-09
23 REGULATORY REGION NUCLEIC ACID BINDING 277 818 2.374e-10 9.589e-09
24 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 46 81 4.073e-10 1.576e-08
25 CALCIUM ION BINDING 240 697 6.93e-10 2.508e-08
26 ION CHANNEL BINDING 57 111 7.018e-10 2.508e-08
27 PROTEIN HOMODIMERIZATION ACTIVITY 246 722 1.299e-09 4.469e-08
28 LIPID BINDING 227 657 1.436e-09 4.766e-08
29 PHOSPHOLIPID BINDING 137 360 3.707e-09 1.188e-07
30 SEQUENCE SPECIFIC DNA BINDING 331 1037 7.942e-09 2.459e-07
31 PHOSPHATIDYLINOSITOL BINDING 85 200 1.097e-08 3.286e-07
32 CALMODULIN BINDING 78 179 1.161e-08 3.37e-07
33 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 125 329 1.97e-08 5.545e-07
34 RECEPTOR SIGNALING PROTEIN ACTIVITY 75 172 2.125e-08 5.807e-07
35 BETA CATENIN BINDING 44 84 2.768e-08 7.347e-07
36 ACTIN FILAMENT BINDING 57 121 3.98e-08 9.993e-07
37 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 116 303 3.883e-08 9.993e-07
38 GTPASE BINDING 113 295 5.593e-08 1.367e-06
39 UBIQUITIN LIKE PROTEIN LIGASE BINDING 103 264 7.338e-08 1.748e-06
40 PROTEIN DIMERIZATION ACTIVITY 356 1149 7.696e-08 1.787e-06
41 GROWTH FACTOR BINDING 57 123 8.133e-08 1.843e-06
42 TRANSPORTER ACTIVITY 390 1276 9.499e-08 2.101e-06
43 DOUBLE STRANDED DNA BINDING 248 764 1.363e-07 2.945e-06
44 ENZYME REGULATOR ACTIVITY 301 959 2.237e-07 4.723e-06
45 TRANSMEMBRANE TRANSPORTER ACTIVITY 311 997 2.657e-07 5.486e-06
46 BINDING BRIDGING 72 173 3.767e-07 7.607e-06
47 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 34 64 6.653e-07 1.315e-05
48 ADENYL NUCLEOTIDE BINDING 446 1514 1.201e-06 2.324e-05
49 GUANYL NUCLEOTIDE BINDING 136 390 1.57e-06 2.977e-05
50 SMAD BINDING 36 72 2.123e-06 3.866e-05
51 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 87 228 2.164e-06 3.866e-05
52 TRANSCRIPTION FACTOR BINDING 174 524 2.153e-06 3.866e-05
53 PDZ DOMAIN BINDING 42 90 3.168e-06 5.552e-05
54 ENZYME ACTIVATOR ACTIVITY 158 471 3.247e-06 5.587e-05
55 PROTEIN TYROSINE KINASE ACTIVITY 70 176 3.862e-06 6.523e-05
56 GTPASE ACTIVITY 91 246 5.756e-06 9.549e-05
57 CORE PROMOTER PROXIMAL REGION DNA BINDING 127 371 9.698e-06 0.0001581
58 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 36 76 1.031e-05 0.0001651
59 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 140 417 1.097e-05 0.0001728
60 COLLAGEN BINDING 32 65 1.166e-05 0.0001805
61 CHANNEL REGULATOR ACTIVITY 54 131 1.426e-05 0.0002172
62 SNARE BINDING 53 128 1.466e-05 0.0002197
63 GLYCOSAMINOGLYCAN BINDING 77 205 1.56e-05 0.00023
64 ZINC ION BINDING 341 1155 1.872e-05 0.0002718
65 TUBULIN BINDING 97 273 1.996e-05 0.0002852
66 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 18 30 3.338e-05 0.0004698
67 KINASE REGULATOR ACTIVITY 70 186 3.444e-05 0.0004775
68 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 48 116 3.705e-05 0.0005061
69 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 40 92 4.243e-05 0.0005713
70 UDP GLYCOSYLTRANSFERASE ACTIVITY 55 139 4.74e-05 0.0006291
71 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 44 105 5.35e-05 7e-04
72 SYNTAXIN BINDING 40 93 5.711e-05 0.0007368
73 X1 PHOSPHATIDYLINOSITOL BINDING 13 19 6.098e-05 0.000776
74 HEPARIN BINDING 60 157 7.272e-05 0.0009129
75 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 12 17 7.444e-05 0.0009221
76 EPHRIN RECEPTOR BINDING 15 24 7.902e-05 0.0009659
77 SULFUR COMPOUND BINDING 83 234 8.15e-05 0.0009833
78 SH3 DOMAIN BINDING 47 116 8.275e-05 0.0009856
79 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 11 15 8.769e-05 0.001031
80 MICROTUBULE BINDING 73 201 9.108e-05 0.001058
81 STEROID HORMONE RECEPTOR ACTIVITY 28 59 9.264e-05 0.001063
82 SIGNALING ADAPTOR ACTIVITY 33 74 0.0001064 0.001205
83 CHROMATIN BINDING 140 435 0.0001091 0.001221
84 CHEMOREPELLENT ACTIVITY 16 27 0.0001133 0.001253
85 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 182 588 0.0001259 0.001376
86 CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 191 622 0.0001403 0.001515
87 UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY 135 420 0.0001525 0.001574
88 TRANSITION METAL ION BINDING 398 1400 0.0001477 0.001574
89 ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 117 356 0.0001513 0.001574
90 LAMININ BINDING 17 30 0.0001492 0.001574
91 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 62 168 0.000178 0.001817
92 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 164 527 0.0001989 0.002009
93 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 0.0002187 0.002161
94 GLYCOPROTEIN BINDING 41 101 0.0002174 0.002161
95 PROTEIN COMPLEX SCAFFOLD 30 68 0.0002714 0.002627
96 CLATHRIN BINDING 29 65 0.00027 0.002627
97 ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 18 34 0.0003038 0.00291
98 ACTIVIN BINDING 9 12 0.0003125 0.002962
99 EXTRACELLULAR MATRIX BINDING 24 51 0.000338 0.003172
100 X14 3 3 PROTEIN BINDING 12 19 0.000367 0.003409
101 UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY 70 199 0.0003706 0.003409
102 TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS 71 203 0.0004083 0.003682
103 PROTEIN C TERMINUS BINDING 66 186 0.0004078 0.003682
104 CORECEPTOR ACTIVITY 19 38 0.0005375 0.004801
105 HISTONE DEACETYLASE BINDING 41 105 0.0005678 0.005024
106 ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 96 293 0.0006307 0.005527
107 PHOSPHATASE BINDING 58 162 0.0006858 0.005845
108 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 24 53 0.0006824 0.005845
109 PHOSPHATIDYLSERINE BINDING 17 33 0.0006747 0.005845
110 CORE PROMOTER BINDING 55 152 0.0006955 0.005874
111 MONOSACCHARIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 20 0.0007145 0.00598
112 FRIZZLED BINDING 18 36 0.0007492 0.006214
113 VOLTAGE GATED ION CHANNEL ACTIVITY 66 190 0.0007855 0.006458
114 BHLH TRANSCRIPTION FACTOR BINDING 15 28 0.0008186 0.006613
115 CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 15 28 0.0008186 0.006613
116 POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 52 143 0.0008405 0.006731
117 STEROID BINDING 36 91 0.0009039 0.007177
118 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 22 48 0.0009231 0.007206
119 MRNA 3 UTR BINDING 22 48 0.0009231 0.007206
120 PHOSPHOPROTEIN BINDING 26 60 0.0009428 0.007239
121 GDP BINDING 23 51 0.0009397 0.007239
122 SYNTAXIN 1 BINDING 11 18 0.0009691 0.007303
123 PLATELET DERIVED GROWTH FACTOR BINDING 8 11 0.0009748 0.007303
124 MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING 11 18 0.0009691 0.007303
125 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 39 101 0.0009829 0.007305
126 UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING 17 34 0.001046 0.007709
127 MOTOR ACTIVITY 48 131 0.001079 0.007892
128 ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 22 49 0.001294 0.009393
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 485 1151 7.828e-43 4.572e-40
2 SYNAPSE 344 754 9.877e-39 2.884e-36
3 NEURON PART 492 1265 1.074e-32 2.091e-30
4 NEURON PROJECTION 386 942 5.751e-31 8.396e-29
5 MEMBRANE REGION 440 1134 5.957e-29 6.958e-27
6 SYNAPSE PART 270 610 6.366e-28 6.196e-26
7 CELL PROJECTION 623 1786 5.509e-26 4.596e-24
8 GOLGI APPARATUS 517 1445 3.003e-24 2.192e-22
9 ANCHORING JUNCTION 218 489 3.197e-23 2.074e-21
10 EXCITATORY SYNAPSE 109 197 8.207e-21 4.793e-19
11 POSTSYNAPSE 173 378 4.042e-20 2.146e-18
12 GOLGI APPARATUS PART 335 893 2.004e-19 9.753e-18
13 CELL SUBSTRATE JUNCTION 178 398 2.321e-19 1.043e-17
14 PLASMA MEMBRANE REGION 345 929 3.556e-19 1.483e-17
15 CELL PROJECTION PART 347 946 2.576e-18 1.003e-16
16 EXTRACELLULAR MATRIX COMPONENT 76 125 4.033e-18 1.423e-16
17 SOMATODENDRITIC COMPARTMENT 256 650 4.144e-18 1.423e-16
18 MEMBRANE MICRODOMAIN 136 288 1.651e-17 5.355e-16
19 CELL LEADING EDGE 157 350 2.228e-17 6.847e-16
20 DENDRITE 190 451 3.406e-17 9.945e-16
21 GOLGI MEMBRANE 267 703 1.855e-16 5.159e-15
22 ENDOPLASMIC RETICULUM 531 1631 2.715e-15 7.206e-14
23 AXON 172 418 1.459e-14 3.705e-13
24 PERINUCLEAR REGION OF CYTOPLASM 241 642 2.609e-14 6.347e-13
25 BASEMENT MEMBRANE 57 93 3.654e-14 8.536e-13
26 INTRACELLULAR VESICLE 417 1259 2.199e-13 4.939e-12
27 CELL CELL JUNCTION 157 383 3.001e-13 6.49e-12
28 CELL SURFACE 271 757 4.147e-13 8.649e-12
29 VACUOLE 390 1180 1.971e-12 3.836e-11
30 PROTEINACEOUS EXTRACELLULAR MATRIX 146 356 1.948e-12 3.836e-11
31 ORGANELLE SUBCOMPARTMENT 130 311 6.534e-12 1.231e-10
32 INTRINSIC COMPONENT OF PLASMA MEMBRANE 517 1649 8.203e-12 1.497e-10
33 PRESYNAPSE 119 283 3.19e-11 5.644e-10
34 EXTRACELLULAR MATRIX 164 426 3.875e-11 6.655e-10
35 ENDOPLASMIC RETICULUM PART 378 1163 5.177e-11 8.638e-10
36 CYTOPLASMIC REGION 119 287 9.333e-11 1.514e-09
37 ACTIN CYTOSKELETON 167 444 2.131e-10 3.363e-09
38 CELL BODY 182 494 2.35e-10 3.612e-09
39 SYNAPTIC MEMBRANE 109 261 3.433e-10 5.141e-09
40 VESICLE MEMBRANE 186 512 5.549e-10 8.102e-09
41 CYTOSKELETON 590 1967 9.001e-10 1.282e-08
42 CELL CORTEX 100 238 1.224e-09 1.662e-08
43 CYTOPLASMIC VESICLE PART 211 601 1.196e-09 1.662e-08
44 PLASMA MEMBRANE PROTEIN COMPLEX 184 510 1.282e-09 1.701e-08
45 LAMELLIPODIUM 77 172 3.331e-09 4.323e-08
46 TRANS GOLGI NETWORK 84 193 3.464e-09 4.398e-08
47 NEURONAL POSTSYNAPTIC DENSITY 33 53 4.935e-09 6.133e-08
48 MYELIN SHEATH 75 168 6.155e-09 7.488e-08
49 AXON PART 91 219 1.282e-08 1.528e-07
50 SITE OF POLARIZED GROWTH 67 149 2.741e-08 3.201e-07
51 FILOPODIUM 47 94 6.248e-08 7.155e-07
52 T TUBULE 28 45 7.385e-08 8.294e-07
53 EXTRINSIC COMPONENT OF MEMBRANE 99 252 8.796e-08 9.692e-07
54 ENDOSOME 257 793 9.41e-08 1.018e-06
55 CORTICAL ACTIN CYTOSKELETON 33 58 1.126e-07 1.196e-06
56 CELL CORTEX PART 55 119 1.522e-07 1.588e-06
57 CORTICAL CYTOSKELETON 41 81 2.783e-07 2.851e-06
58 NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK 313 1005 2.859e-07 2.879e-06
59 VACUOLAR PART 226 694 3.734e-07 3.696e-06
60 APICAL JUNCTION COMPLEX 57 128 4.315e-07 4.2e-06
61 RUFFLE 66 156 5.586e-07 5.347e-06
62 PLASMA MEMBRANE RAFT 42 86 7.009e-07 6.602e-06
63 CLATHRIN COATED VESICLE 66 157 7.364e-07 6.826e-06
64 COMPLEX OF COLLAGEN TRIMERS 17 23 7.635e-07 6.967e-06
65 POSTSYNAPTIC MEMBRANE 81 205 9.581e-07 8.608e-06
66 LEADING EDGE MEMBRANE 58 134 1.085e-06 9.603e-06
67 ENDOPLASMIC RETICULUM LUMEN 79 201 1.655e-06 1.443e-05
68 EXOCYTIC VESICLE 60 142 1.882e-06 1.616e-05
69 NEURON SPINE 53 121 2.004e-06 1.696e-05
70 APICAL PART OF CELL 127 361 2.057e-06 1.716e-05
71 CELL CELL CONTACT ZONE 33 64 2.334e-06 1.919e-05
72 EXOCYTIC VESICLE MEMBRANE 30 56 2.378e-06 1.929e-05
73 GOLGI STACK 54 125 2.696e-06 2.157e-05
74 MEMBRANE PROTEIN COMPLEX 310 1020 3.524e-06 2.781e-05
75 EARLY ENDOSOME 108 301 4.216e-06 3.283e-05
76 CATION CHANNEL COMPLEX 67 167 4.345e-06 3.339e-05
77 APICAL PLASMA MEMBRANE 105 292 5.091e-06 3.862e-05
78 NUCLEAR ENVELOPE 141 416 5.851e-06 4.381e-05
79 MAIN AXON 30 58 6.131e-06 4.533e-05
80 TRANSPORT VESICLE 118 338 7.044e-06 5.142e-05
81 CONTRACTILE FIBER 80 211 7.193e-06 5.186e-05
82 SIDE OF MEMBRANE 144 428 7.29e-06 5.192e-05
83 CYTOPLASMIC SIDE OF MEMBRANE 67 170 8.829e-06 6.212e-05
84 ACTOMYOSIN 31 62 1.065e-05 7.404e-05
85 NEUROMUSCULAR JUNCTION 28 54 1.169e-05 8.034e-05
86 COATED VESICLE 86 234 1.365e-05 9.269e-05
87 SARCOLEMMA 52 125 1.504e-05 0.0001009
88 RUFFLE MEMBRANE 37 80 1.542e-05 0.0001023
89 GOLGI CISTERNA 41 93 2.299e-05 0.0001509
90 TERMINAL BOUTON 31 64 2.399e-05 0.0001557
91 CELL PROJECTION MEMBRANE 104 298 2.431e-05 0.000156
92 VACUOLAR MEMBRANE 186 587 2.491e-05 0.0001581
93 BASOLATERAL PLASMA MEMBRANE 78 211 2.651e-05 0.0001664
94 LYTIC VACUOLE 168 526 3.767e-05 0.000234
95 GOLGI CISTERNA MEMBRANE 34 74 3.988e-05 0.0002451
96 ACTIN BASED CELL PROJECTION 68 181 4.71e-05 0.0002865
97 CLATHRIN COATED VESICLE MEMBRANE 36 81 5.752e-05 0.0003428
98 TRANS GOLGI NETWORK MEMBRANE 36 81 5.752e-05 0.0003428
99 ENDOCYTIC VESICLE 90 256 6.097e-05 0.0003561
100 COSTAMERE 13 19 6.098e-05 0.0003561
101 TRANSPORT VESICLE MEMBRANE 58 151 8.065e-05 0.0004663
102 INTERCALATED DISC 25 51 0.000113 0.0006467
103 RECEPTOR COMPLEX 109 327 0.0001349 0.0007598
104 FILAMENTOUS ACTIN 13 20 0.0001353 0.0007598
105 POTASSIUM CHANNEL COMPLEX 38 90 0.0001389 0.0007726
106 CLATHRIN COAT 23 46 0.0001438 0.0007925
107 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 17 30 0.0001492 0.0008143
108 CELL DIVISION SITE 25 52 0.0001676 0.0009062
109 PRESYNAPTIC MEMBRANE 26 55 0.0001768 0.0009473
110 COLLAGEN TRIMER 37 88 0.0001873 0.0009944
111 ENDOCYTIC VESICLE MEMBRANE 57 152 0.0001958 0.00103
112 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 40 98 0.000225 0.001173
113 TRANSPORTER COMPLEX 106 321 0.0002466 0.001274
114 OUTER MEMBRANE 68 190 0.0002542 0.001302
115 BASAL LAMINA 13 21 0.000276 0.001402
116 PARANODE REGION OF AXON 9 12 0.0003125 0.001573
117 BASAL PART OF CELL 24 51 0.000338 0.001687
118 NEURON PROJECTION TERMINUS 49 129 0.0003756 0.001859
119 LYSOSOMAL LUMEN 36 88 0.00043 0.00211
120 NUCLEAR MEMBRANE 93 280 0.0004589 0.002233
121 MICROTUBULE CYTOSKELETON 306 1068 0.0004933 0.002361
122 TRANS GOLGI NETWORK TRANSPORT VESICLE 15 27 0.0004897 0.002361
123 COATED PIT 29 67 0.0005032 0.002389
124 I BAND 46 121 0.0005459 0.002571
125 SECRETORY VESICLE 143 461 0.0005714 0.002669
126 NODE OF RANVIER 10 15 0.0006267 0.002905
127 MICROTUBULE ASSOCIATED COMPLEX 53 145 0.0006558 0.003016
128 BASAL PLASMA MEMBRANE 17 33 0.0006747 0.003078
129 LIPID PARTICLE 27 62 0.000691 0.003128
130 PROTEIN KINASE COMPLEX 36 90 0.0007107 0.003193
131 CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE 22 48 0.0009231 0.004115
132 CLATHRIN VESICLE COAT 13 23 0.0009386 0.004152
133 ACTIN FILAMENT BUNDLE 25 57 0.0009485 0.004165
134 MICROTUBULE 126 405 0.001036 0.004513
135 PLASMA MEMBRANE RECEPTOR COMPLEX 61 175 0.0011 0.004758
136 CYTOSKELETAL PART 398 1436 0.001202 0.005123
137 VACUOLAR LUMEN 43 115 0.001201 0.005123
138 ENDOSOMAL PART 132 430 0.001412 0.005976
139 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 49 136 0.001464 0.006153
140 EARLY ENDOSOME MEMBRANE 42 113 0.001556 0.006492
141 SARCOPLASM 28 68 0.001589 0.006583
142 PLATELET ALPHA GRANULE 30 75 0.001903 0.007825
143 CELL CELL ADHERENS JUNCTION 23 54 0.002389 0.009758
144 BRUSH BORDER 38 102 0.002416 0.009798

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 97 200 8.733e-14 1.572e-11
2 hsa04360_Axon_guidance 69 130 1.544e-12 1.39e-10
3 hsa04014_Ras_signaling_pathway 105 236 8.004e-12 4.802e-10
4 hsa04512_ECM.receptor_interaction 49 85 5.287e-11 2.379e-09
5 hsa04151_PI3K_AKT_signaling_pathway 139 351 1.25e-10 4.499e-09
6 hsa04390_Hippo_signaling_pathway 71 154 2.897e-09 8.406e-08
7 hsa04810_Regulation_of_actin_cytoskeleton 91 214 3.269e-09 8.406e-08
8 hsa04010_MAPK_signaling_pathway 106 268 2.062e-08 4.639e-07
9 hsa04916_Melanogenesis 48 101 3.283e-07 6.566e-06
10 hsa04144_Endocytosis 80 203 1.26e-06 2.268e-05
11 hsa04310_Wnt_signaling_pathway 63 151 1.772e-06 2.9e-05
12 hsa04920_Adipocytokine_signaling_pathway 34 68 4.043e-06 6.065e-05
13 hsa04514_Cell_adhesion_molecules_.CAMs. 57 136 4.554e-06 6.305e-05
14 hsa04960_Aldosterone.regulated_sodium_reabsorption 24 42 5.456e-06 7.015e-05
15 hsa04910_Insulin_signaling_pathway 57 138 7.775e-06 9.33e-05
16 hsa04540_Gap_junction 41 90 8.694e-06 9.78e-05
17 hsa04520_Adherens_junction 34 73 2.808e-05 0.0002973
18 hsa04270_Vascular_smooth_muscle_contraction 48 116 3.705e-05 0.0003705
19 hsa04722_Neurotrophin_signaling_pathway 51 127 5.577e-05 0.0005177
20 hsa04974_Protein_digestion_and_absorption 36 81 5.752e-05 0.0005177
21 hsa04020_Calcium_signaling_pathway 66 177 7.859e-05 0.0006736
22 hsa04012_ErbB_signaling_pathway 37 87 0.0001414 0.001157
23 hsa04350_TGF.beta_signaling_pathway 36 85 0.000191 0.00149
24 hsa04730_Long.term_depression 31 70 0.0001987 0.00149
25 hsa04666_Fc_gamma_R.mediated_phagocytosis 39 95 0.0002324 0.001673
26 hsa04380_Osteoclast_differentiation 49 128 0.0003038 0.002103
27 hsa00510_N.Glycan_biosynthesis 23 49 0.0004677 0.003118
28 hsa04973_Carbohydrate_digestion_and_absorption 21 44 0.000619 0.003979
29 hsa04710_Circadian_rhythm_._mammal 13 23 0.0009386 0.005826
30 hsa04720_Long.term_potentiation 29 70 0.00118 0.006952
31 hsa04210_Apoptosis 35 89 0.001197 0.006952
32 hsa04530_Tight_junction 48 133 0.001562 0.008786
33 hsa04070_Phosphatidylinositol_signaling_system 31 78 0.001822 0.009798
34 hsa04141_Protein_processing_in_endoplasmic_reticulum 58 168 0.001851 0.009798
35 hsa04912_GnRH_signaling_pathway 38 101 0.001971 0.01014
36 hsa04914_Progesterone.mediated_oocyte_maturation 33 87 0.003241 0.0162
37 hsa00533_Glycosaminoglycan_biosynthesis_._keratan_sulfate 9 15 0.003425 0.01666
38 hsa04662_B_cell_receptor_signaling_pathway 29 75 0.004043 0.01915
39 hsa04340_Hedgehog_signaling_pathway 23 56 0.004164 0.01922
40 hsa04971_Gastric_acid_secretion 28 74 0.006623 0.0298
41 hsa04150_mTOR_signaling_pathway 21 52 0.007575 0.03326
42 hsa04320_Dorso.ventral_axis_formation 12 25 0.008531 0.03656
43 hsa04115_p53_signaling_pathway 26 69 0.009226 0.03786
44 hsa04970_Salivary_secretion 32 89 0.009254 0.03786
45 hsa04962_Vasopressin.regulated_water_reabsorption 18 44 0.01111 0.04446
46 hsa04062_Chemokine_signaling_pathway 58 189 0.02705 0.1058
47 hsa00250_Alanine._aspartate_and_glutamate_metabolism 13 32 0.03058 0.1171
48 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 11 26 0.03321 0.1233
49 hsa04370_VEGF_signaling_pathway 26 76 0.03358 0.1233
50 hsa04260_Cardiac_muscle_contraction 26 77 0.03929 0.1414
51 hsa00512_Mucin_type_O.Glycan_biosynthesis 12 30 0.0418 0.1475
52 hsa00670_One_carbon_pool_by_folate 8 18 0.0492 0.1703
53 hsa04664_Fc_epsilon_RI_signaling_pathway 26 79 0.05283 0.1794
54 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 17 48 0.05627 0.1853
55 hsa04972_Pancreatic_secretion 32 101 0.05661 0.1853
56 hsa04142_Lysosome 37 121 0.06928 0.2227
57 hsa04976_Bile_secretion 23 71 0.07683 0.2386
58 hsa04130_SNARE_interactions_in_vesicular_transport 13 36 0.0769 0.2386
59 hsa00330_Arginine_and_proline_metabolism 18 54 0.08606 0.2595
60 hsa04330_Notch_signaling_pathway 16 47 0.08649 0.2595
61 hsa00280_Valine._leucine_and_isoleucine_degradation 15 44 0.09399 0.2696
62 hsa02010_ABC_transporters 15 44 0.09399 0.2696
63 hsa04120_Ubiquitin_mediated_proteolysis 41 139 0.09435 0.2696
64 hsa00030_Pentose_phosphate_pathway 10 27 0.09762 0.2746
65 hsa04640_Hematopoietic_cell_lineage 27 88 0.1044 0.2869
66 hsa04114_Oocyte_meiosis 34 114 0.1052 0.2869
67 hsa00562_Inositol_phosphate_metabolism 18 57 0.1318 0.3502
68 hsa00230_Purine_metabolism 46 162 0.1323 0.3502
69 hsa00500_Starch_and_sucrose_metabolism 17 54 0.1433 0.3634
70 hsa00410_beta.Alanine_metabolism 8 22 0.1434 0.3634
71 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 8 22 0.1434 0.3634
72 hsa00564_Glycerophospholipid_metabolism 24 80 0.1463 0.3658
73 hsa00600_Sphingolipid_metabolism 13 40 0.1535 0.3786
74 hsa03010_Ribosome 27 92 0.1579 0.3841
75 hsa04660_T_cell_receptor_signaling_pathway 31 108 0.1705 0.4093
76 hsa00052_Galactose_metabolism 9 27 0.1903 0.4506
77 hsa00071_Fatty_acid_metabolism 13 43 0.2298 0.5373
78 hsa00640_Propanoate_metabolism 10 32 0.2345 0.5411
79 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 5 14 0.239 0.5446
80 hsa00270_Cysteine_and_methionine_metabolism 11 36 0.2437 0.5482
81 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 8 26 0.2863 0.6363
82 hsa00100_Steroid_biosynthesis 6 19 0.3071 0.6742
83 hsa00910_Nitrogen_metabolism 7 23 0.3183 0.6822
84 hsa04964_Proximal_tubule_bicarbonate_reclamation 7 23 0.3183 0.6822
85 hsa00400_Phenylalanine._tyrosine_and_tryptophan_biosynthesis 2 5 0.3531 0.7476
86 hsa04630_Jak.STAT_signaling_pathway 40 155 0.3632 0.7601
87 hsa00040_Pentose_and_glucuronate_interconversions 9 32 0.3721 0.7644
88 hsa00565_Ether_lipid_metabolism 10 36 0.3752 0.7644
89 hsa04145_Phagosome 40 156 0.3806 0.7644
90 hsa00983_Drug_metabolism_._other_enzymes 14 52 0.3822 0.7644
91 hsa00360_Phenylalanine_metabolism 5 17 0.4005 0.7824
92 hsa04670_Leukocyte_transendothelial_migration 30 117 0.4049 0.7824
93 hsa00340_Histidine_metabolism 8 29 0.4098 0.7824
94 hsa00350_Tyrosine_metabolism 11 41 0.4126 0.7824
95 hsa04672_Intestinal_immune_network_for_IgA_production 13 49 0.4129 0.7824
96 hsa03320_PPAR_signaling_pathway 18 70 0.4387 0.8102
97 hsa00561_Glycerolipid_metabolism 13 50 0.445 0.8102
98 hsa00750_Vitamin_B6_metabolism 2 6 0.4501 0.8102
99 hsa04140_Regulation_of_autophagy 9 34 0.4502 0.8102
100 hsa00053_Ascorbate_and_aldarate_metabolism 7 26 0.4527 0.8102
101 hsa00630_Glyoxylate_and_dicarboxylate_metabolism 5 18 0.4546 0.8102
102 hsa00531_Glycosaminoglycan_degradation 5 19 0.5073 0.8952
103 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 4 15 0.5144 0.8981
104 hsa04610_Complement_and_coagulation_cascades 17 69 0.5226 0.8981
105 hsa00290_Valine._leucine_and_isoleucine_biosynthesis 3 11 0.5239 0.8981
106 hsa00260_Glycine._serine_and_threonine_metabolism 8 32 0.5326 0.9045
107 hsa00232_Caffeine_metabolism 2 7 0.5382 0.9055
108 hsa00760_Nicotinate_and_nicotinamide_metabolism 6 24 0.5477 0.9129
109 hsa00770_Pantothenate_and_CoA_biosynthesis 4 16 0.5706 0.9423
110 hsa00514_Other_types_of_O.glycan_biosynthesis 11 46 0.5829 0.9443
111 hsa00380_Tryptophan_metabolism 10 42 0.5905 0.9443
112 hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis 6 25 0.5919 0.9443
113 hsa04621_NOD.like_receptor_signaling_pathway 14 59 0.5928 0.9443
114 hsa04620_Toll.like_receptor_signaling_pathway 24 102 0.6127 0.9667
115 hsa00450_Selenocompound_metabolism 4 17 0.623 0.9667
116 hsa00511_Other_glycan_degradation 4 17 0.623 0.9667
117 hsa00010_Glycolysis_._Gluconeogenesis 15 65 0.6401 0.9848
118 hsa00051_Fructose_and_mannose_metabolism 8 36 0.6781 1
119 hsa03060_Protein_export 5 23 0.6914 1
120 hsa04110_Cell_cycle 29 128 0.7031 1
121 hsa04122_Sulfur_relay_system 2 10 0.7406 1
122 hsa04650_Natural_killer_cell_mediated_cytotoxicity 30 136 0.7615 1
123 hsa00650_Butanoate_metabolism 6 30 0.7733 1
124 hsa00790_Folate_biosynthesis 2 11 0.7888 1
125 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 4 21 0.7889 1
126 hsa00620_Pyruvate_metabolism 8 40 0.7918 1
127 hsa04614_Renin.angiotensin_system 3 17 0.8206 1
128 hsa03022_Basal_transcription_factors 7 37 0.8309 1
129 hsa03013_RNA_transport 32 152 0.8513 1
130 hsa00140_Steroid_hormone_biosynthesis 11 57 0.8519 1
131 hsa03018_RNA_degradation 14 71 0.8529 1
132 hsa04622_RIG.I.like_receptor_signaling_pathway 14 71 0.8529 1
133 hsa04977_Vitamin_digestion_and_absorption 4 24 0.8703 1
134 hsa00310_Lysine_degradation 8 44 0.8725 1
135 hsa00982_Drug_metabolism_._cytochrome_P450 14 73 0.8799 1
136 hsa00590_Arachidonic_acid_metabolism 11 59 0.8817 1
137 hsa03450_Non.homologous_end.joining 2 14 0.8891 1
138 hsa00480_Glutathione_metabolism 9 50 0.89 1
139 hsa00592_alpha.Linolenic_acid_metabolism 3 20 0.8975 1
140 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 13 71 0.9106 1
141 hsa00900_Terpenoid_backbone_biosynthesis 2 15 0.9112 1
142 hsa04966_Collecting_duct_acid_secretion 4 27 0.9231 1
143 hsa04612_Antigen_processing_and_presentation 14 78 0.9304 1
144 hsa03015_mRNA_surveillance_pathway 15 83 0.9318 1
145 hsa04146_Peroxisome 14 79 0.9379 1
146 hsa00190_Oxidative_phosphorylation 25 132 0.9427 1
147 hsa03020_RNA_polymerase 4 29 0.9466 1
148 hsa00591_Linoleic_acid_metabolism 4 30 0.9557 1
149 hsa03420_Nucleotide_excision_repair 6 45 0.9774 1
150 hsa03410_Base_excision_repair 4 34 0.9795 1
151 hsa03440_Homologous_recombination 3 28 0.9801 1
152 hsa04975_Fat_digestion_and_absorption 6 46 0.981 1
153 hsa00240_Pyrimidine_metabolism 16 99 0.9818 1
154 hsa00830_Retinol_metabolism 9 64 0.9851 1
155 hsa03430_Mismatch_repair 2 23 0.9863 1
156 hsa00860_Porphyrin_and_chlorophyll_metabolism 5 43 0.9886 1
157 hsa03050_Proteasome 5 45 0.9923 1
158 hsa04742_Taste_transduction 6 52 0.9936 1
159 hsa03008_Ribosome_biogenesis_in_eukaryotes 11 81 0.9943 1
160 hsa03030_DNA_replication 3 36 0.9966 1
161 hsa04744_Phototransduction 2 29 0.9968 1
162 hsa00020_Citrate_cycle_.TCA_cycle. 2 30 0.9975 1
163 hsa04623_Cytosolic_DNA.sensing_pathway 5 56 0.9992 1
164 hsa00970_Aminoacyl.tRNA_biosynthesis 6 63 0.9993 1
165 hsa03040_Spliceosome 11 128 1 1
166 hsa04740_Olfactory_transduction 8 388 1 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

PART1

 hsa-miR-181b-5p;hsa-miR-193b-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-223-3p;hsa-miR-23a-3p;hsa-miR-25-3p;hsa-miR-3614-5p;hsa-miR-629-5p;hsa-miR-92a-3p 10 KSR2 Sponge network 2.634 0.03419 0.29 0.66769 0.423
2

PART1

 hsa-miR-146a-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-193b-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-197-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-92a-3p 10 FOXP2 Sponge network 2.634 0.03419 0.262 0.75107 0.29

Quest ID: 42f4d9c0e6eb02b16ca24c8962ff7a01